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Abstract 
The development of tunable polymers has become increasingly important for both tissue 
engineering and drug delivery. This thesis investigates the development of water-soluble 
polyesters that contain both natural and synthetic components. These polymers offer 
tunable chemical structures, as well as functional groups for the conjugation of crosslinking 
moieties or cell signaling molecules. The first series of polymers was synthesized from 
poly(ethylene glycol) (PEG) and aspartic acid (Asp) via a titanium catalyzed 
transesterification method to provide polymers with molar masses of 12 kg/mol. After 
deprotection, the pendent functional groups of Asp were reacted with methacrylic, maleic, 
and itaconic anhydride to introduce crosslinkable functional groups. A thermally-initiated 
crosslinking method was used to prepare hydrogels from the methacrylamide-
functionalized polymers. The resulting hydrogels were assessed based on their physical 
and mechanical properties. High cell content (> 95%) and compressive moduli of 6 – 9 
MPa were obtained were obtained for selected systems. Adipose derived stromal cells were 
encapsulated within these hydrogels and high cell viabilities indicated that they are 
promising as scaffolds for potential therapeutic or cell delivery. A second series of 
polyesters was prepared from PEG, Asp, and itaconic acid, thereby providing polymers 
with both crosslinkable moieties as well as functional groups for further bioconjugation. 
The backbone itaconate groups were crosslinked via thermally-initiated free radical 
crosslinking. Hydrogels were obtained, but the gel content was relatively low, indicating 
that further optimization of the polymer structure or crosslinking conditions will be needed 
in the future.     
 
Keywords 
Biodegradable polymers, polyesters, itaconic acid, aspartic acid, hydrogels, adipose-
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Summary for lay audience 
Polymers offer an exciting area of research in the field of biomedical engineering because 
they can break down naturally in the body. This is especially important in the field of tissue 
engineering, which uses polymers to act as delivery vehicles for cells and drugs to enter 
the body. This thesis describes the formation of polymers that contain both amino acids 
and synthetic polymers. The combination of both natural and synthetic components can 
provide polymers that are both mechanically compatible with the body and non-toxic. The 
polymers were prepared containing components that can be obtained from renewable 
resources such as algae. To mimic the environment found within the body, these polymers 
are made to be water-soluble. They were then used to form a hydrogel, which is 3-
dimensional network comprised of polymer chains. Hydrogels have a high-water content 
and mechanical properties which are similar to living tissue found within the body. The 
process used to form the hydrogel was initiated by heat, which potentially allows for the 
solution to be injected into the body as a liquid and form a gel once inside the body. 
Different polymer systems were used to synthesize various hydrogels and they were 
assessed based on their physical properties, such as how much the hydrogel swells. 
Hydrogels that formed a dense network were further analyzed. Stem cells derived from fat 
tissue were then encapsulated into the gel and the survival of the cells was assessed. The 
cells survived within the gel, which indicates that the gel itself is not toxic. Overall, this 
thesis lays the foundation for a new series of gel scaffolds that can be used to encapsulate 
cells and deliver them into the body.    
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Chapter 1  
1 Introduction 
Polymers have been widely used in our global society for centuries with commercial 
applications such as rubber tires, plastic bags and polyester clothing. However, only in the 
last few decades has the possibility of using polymers for biomedical applications been 
heavily explored.1 The work of Dr. Robert Langer has largely pioneered a field in which 
polymers can be used as vehicles for drug delivery, or fabricated into scaffolds designed 
for tissue engineering.2 A common objective of the vast majority of biomedical polymers 
is their desired inert effects on the human body. To achieve a limited host response, there 
has been increasing interest in biodegradable polymers. The degradation of the polymers 
through enzymatic and hydrolytic pathways limits the duration of polymer’s exposure to 
the host environment, and allows for removal of the polymer system via metabolic and 
excretory pathways.3-4 Additionally, degradable polymers prevent the need for invasive 
surgical removal. It is important to note that when designing degradable polymer systems, 
the degradation products of the polymer must also be compatible in vivo. Furthermore, the 
chemical properties of a polymer such as molecular weight, solubility, and hydrophilicity 
have a large impact on in vivo performance and must be carefully considered. Thermal 
properties such as the glass transition temperature and mechanical properties such as the 
compressive modulus, should also be evaluated and tailored to the desired application. For 
example, polymers that are used to deliver therapeutics within the knee joint must be able 
to endure a greater compressive strain than polymers used within non-weight bearing 
locations of the body. To develop an optimal biodegradable polymer system, polymers 
derived from both synthetic and natural sources should be considered.  
1.1 Natural polymers used for biomedical applications  
To ensure host compatibility, natural polymers have been investigated for use in drug 
delivery and tissue engineering. Natural polymers occur in the environment and possess a 
promising ability to mimic the extracellular matrix (ECM). In creating an environment that 
 
2 
simulates the chemical and mechanical cues found in native tissue, the likelihood of cell 
proliferation is increased, while that of host rejection is decreased. 5 
1.1.1 Gelatin  
Gelatin is a natural biopolymer that is derived from collagen (Figure 1.1). It is prepared 
through the hydrolysis of collagen via alkaline, acidic or enzymatic pathways.5 Gelatin is 
composed of the same amino acid sequence as collagen; however, it differs from collagen 
in structure and solubility. Collagen has been observed to produce a greater immune 
response as a result of its tertiary structure and pendent amino acids.6 However, relative to 
collagen, gelatin offers improved solubility in aqueous environments. Gelatin is a widely 
used biomaterial due to a variety of factors, most notability, its effectiveness in cellular 
adhesion due to the abundance of arginine-glycine-aspartic (RGD) sequences.6 Gelatin is 
also favored due to its biodegradability, low immunogenicity and low cost. Gelatin can be 
extracted from sources such as fish, cow bones, and pig skin.7 Although collagen is highly 
present in the ECM, some researches have used gelatin as a substitute due to its reduced 
antigenic properties.8 The thermal and mechanical properties of gelatin are highly tunable 
and are determined by a variety of factors including the collagen source, the extraction 
method and the extent of the hydrolysis. Gelatin also possesses a variety of functional 
handles, which allow for simple chemical modification. For example, methacrylate groups 
(GelMA) can be incorporated for use in covalent crosslinking.9 Gelatin has additionally 
been used to synthesize nanoparticles for use in drug delivery.7  
 
 
3 
n 
Figure 1.1. Chemical structure of gelatin. 
Gelatin has proven successful in the therapeutic delivery of various hydrophilic and 
hydrophobic drugs due to its reproducible production, low cost, and low cytotoxicity. 
Gelatin has also been used extensively in tissue engineering due to reports of improved 
cellular infiltration, adhesion and proliferation on scaffolds containing geletin.6-8, 10-11 Due 
to the aqueous solubility of gelatin, it is an ideal material for synthesizing hybrid hydrogel 
scaffolds with synthetic hydrophilic polymers such as poly(ethylene glycol) (PEG). 
Gelatin-PEG hybrid scaffolds are attractive due to the improved mechanical properties 
exhibited by crosslinking with PEG and favorable cellular adhesion induced by gelatin. 
Overall, gelatin is an attractive natural biomaterial that is ideal for applications where good 
cellular adhesion is required. Because of its weak mechanical properties, blended gelatin 
materials are favored for their improved properties.12  
1.1.2 Collagen  
Collagen is a widely used biopolymer because it is the most prevalent protein found within 
the human body, and plays an important role in tissue formation and cellular adherence 
(Figure 1.2).13 There are over 22 different types of collagen that have been identified within 
the body. Type I collagen has been found to be the most abundant within mammals.14 
Additionally, collagen largely comprises the ECM, making it an attractive material for 
applications in vivo.15 Collagen is a degradable polymer, the degradation components of 
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which have been found to be non-toxic. Collagen has been used extensively to design 
scaffolds for tissue engineering.15  
 
Figure 1.2. Chemical structure of collagen. 
Commercial collagen-based products are largely focused on wound and skin repair and are 
available under names such as Apligraf®, OrCel®, and Promogran.16-18 Zimmer/NeuColl, 
created a synthetic bone graft named Collagraft® which was approved by the FDA in 
1991.19 This approval pioneered an avenue for other collagen-based products to become 
available on the market. Recent studies have also explored using collagen as a hemostatic 
agent due to its high thrombogenicity. This use has allowed the commercialization of 
products such as Floseal® and Sulzer-Spine.3, 20 Further research has investigated the 
efficacy of collagen in protein carriers due to its ability to from crosslinked sponge-like 
structures.21 However, like many naturally occurring polymer systems, controlling batch 
to batch variability of animal derived collagen poses a challenge. There can be 
inconsistency in the physiochemical and mechanical properties of the material. Collagen 
also exhibits poor water solubility, which has complicated its use in developing hydrogel 
systems.21  Nevertheless, given its natural abundance and effective use commercially, 
collagen is a very promising natural polymer that will continue to expand the field of 
biomedical engineering.  
1.1.3 Alginate  
Alginate is an anionic biopolymer that has been favoured for its limited host response, low 
cost and simple gelation conditions (Figure 1.3).22 Alginate is abundant as it can be derived 
from brown seaweed and bacteria. The structure of alginate comprises alternating blocks 
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of β-D-mannuronate (M) and α-L-guluronate (G) residues.23 The composition of the G and 
M residues varies depending on the source of the alginate. The anionic nature of the 
polymer allows it to be gelled through the addition of divalent cations, such as Ca2+, which 
have shown to complex exclusively with the G-blocks of the polymer.24 
 
Figure 1.3. Chemical structure of alginate showing the alternating blocks of β-D-
mannuronate (M) and α-L-guluronate (G) residues.25 Reproduced with permission from 
reference 25. Copyright 2003, Elsevier. 
To enhance the mechanical properties of ionically bound hydrogels, the molecular weight 
and G-block composition can both be increased. The simple addition of calcium chloride 
to a solution of alginate in phosphate buffered saline (PBS) allows for the formation of 
hydrogels. These ionically crosslinked hydrogels have exhibited weak mechanical 
properties.26 Covalently bound hydrogels using alginate and various polymers, including 
hydroxypropyl methylcellulose, have been synthesized to improve these properties.27 
Alginate hydrogels have been found to possess structural properties similar to the ECM, 
making them attractive for tissue engineering applications. Alginate has also been used 
commercially for the treatment of acid reflux under the commercial name Gaviscon	®. 
Furthermore, alginate has also been used as a wound dressing material with products such 
as Algicell®, Kaltostat® and Tegagen®28. Alginate is incredibly prevalent in the natural 
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world, making it a strong candidate for large scale use as a biomaterial. However, due to 
its relatively weak mechanical properties and lack of degradation in vivo, its commercial 
applications have been limited.  
1.1.4 Chitin/Chitosan  
Chitosan is a biodegradable polysaccharide that is widely used in tissue engineering and 
drug delivery (Figure 1.4). Chitosan is derived from chitin, a polymer commonly found in 
the exoskeletons of crustaceans and insects. To form chitosan, chitin is partially 
deacetylated into a polymer composed of glucosamine and N-acetyl glucosamine.29 
Chitosan is widely used in the biomedical field due to its biodegradability, low toxicity, 
and antimicrobial properties.30 Its effectiveness in various applications is highly dependent 
upon the degree of deacetylation and the molecular weight of the chitosan.31. Chitosan also 
possesses reactive side groups which provide excellent functional handles for covalent 
crosslinking. However, a significant hinderance to the commercial use of chitosan is its 
inherently poor solubility in water. Chitosan is insoluble at physiological pH and requires 
an acidic environment (pH < 6) to be solubilized.32  
 
 
Figure 1.4. Deacetylation of chitin to form chitosan.33 Figure reproduced from MDPI 
open access journal. 
Chitosan has been shown to form brittle hydrogels.29  Thus, to improve the ductility of the 
material, various copolymer systems have been synthesized, such as PEG-chitosan 
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copolymers, or it has been covalently crosslinked with glutaraldehyde.5 The protonated 
amino (-NH3+) groups are responsible for the antibacterial effects of chitosan. While the 
exact mechanism remains unknown, it is hypothesized that low-molecular weight chitosan 
can penetrate the bacterial cell wall and bind with anionic DNA, which results in inhibition 
of transcription and mRNA synthesis.34  High molecular weight chitosan has been proven 
successful in diffusion-based drug delivery systems as the long polymer chains effectively 
entrap therapeutics within the network.34 Additionally, nanoparticles have been 
synthesized from chitosan. These particles have shown promise when crosslinked with 
FeCl3 and CaCl2, and exhibit a strong antibacterial effect.35 While there is promising 
research being conducted with chitosan, its commercial efficacy remains largely dependent 
upon further improving its solubility and mechanical properties.  
1.2 Synthetic polymers used for biomedical 
engineering  
While natural polymers have proven effective in certain biomedical applications, they are 
limited by relatively poor mechanical properties, batch to batch variability and limited 
ability to be chemically modified. Synthetic polymers are a good alternative as they are 
highly tunable and have mechanical properties that can be altered in accordance with the 
desired application.  
1.2.1 PLA 
Polylactic acid (PLA) is a hydrophobic aliphatic polyester derived from lactic acid. Due to 
PLA being comprised of lactic acid, which is produced within the body, its degradation 
products are non-toxic and the polymer is also well tolerated in vivo in many applications.36 
In vivo, PLA is subject to hydrolytic degradation of its ester backbone and subsequent 
further breakdown of lactide, making it a biodegradable polymer. Consequently, PLA has 
been used extensively for a variety biomedical applications. There are two stereochemical 
forms of the monomer that are commercially available, D-lactide and L-lactide. The isomer 
found within the body is L-lactide.37 Varying the ratios of L and D-lactide alters the 
properties of the polymer. Polymers comprised solely of L-lactide (PLLA) are semi-
crystalline, while poly(D,L-lactide) (PDLLA) is amorphous (Figure 1.5). The glass 
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transition temperatures (Tg) of PLLA and PDLLA are 68 oC and 53 oC respectively.37 
PLLA is a significantly stiffer polymer with a Young’s modulus of approximately 20 GPA, 
while the Young’s modulus of PDLLA is 2.8 GPA.38 
 
 
Figure 1.5. Chemical structures of PLLA and PDLLA.  
The commercial success in using PLA is largely due to the fact that it can be produced 
inexpensively through the ring opening polymerization of lactide in the presence of a metal 
catalyst.39 Additionally, lactide can be obtained from renewable sources such as corn, 
sugarcane and cassava. Due to the high Young’s modulus and tensile strength of PLLA, 
many of its commercial applications are focused in the orthopedic space as implants and 
fracture fixation devices.40 PDLLA has been used in tissue engineering and drug delivery 
due to its low Young’s modulus and faster degradation rate than PLLA.38 However, due to 
its hydrophobic nature, applications have been somewhat limited. PLA must be used in a 
co-polymer system with a polymer such as PEG to generate water-soluble materials.41 It is 
also limited by its brittle mechanical properties and poor thermal stability. Additionally, as 
the material degrades, the accumulation of acidic by-products can also cause a drop in local 
pH, which can result in irritation.42  
1.2.2 PGA/PLGA 
Poly(glycolic acid) (PGA) is a thermoplastic polyester and is the simplest linear aliphatic 
polyester. It is derived from glycolic acid and is produced industrially through a 
polycondensation or ring-opening polymerization (Figure 1.6a). It first gained commercial 
success in the 1970s with the introduction of a degradable suture called DEXON.43 PGA 
is a highly crystalline polymer with a crystallinity between 45-55%. Additionally, PGA is 
insoluble in most organic solvents.44 Relative to PLA, the degradation of PGA is fairly 
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rapid, due to the absence of the hydrophobic methyl group found on PLA, which slows 
down hydrolysis.45 The Tg of PGA is 35–40 oC, lower than that of PLA.46  The low 
solubility and high degradability of PGA has limited its biomedical applications. However, 
researchers often use PGA in a copolymer system to take advantage of the rapid 
degradation rate. Examples of copolymers of glycolic acid include poly(glycolide-co-
caprolactone) (PGCL) and poly(glycolide-co-trimethylene carbonate) which are both used 
for biomedical applications. Nevertheless, the most researched and commercially abundant 
copolymer is poly(lactic-co-glycolic acid) (PLGA), which incorporates both glycolic and 
lactic acid monomers (Figure 1.6b).47 PLGA is synthesized through a ring opening 
polymerization in the presence of a metal catalyst such as tin(II) 2-ethylhexanoate.  
 
Figure 1.6. Chemical structures of a) PGA and b) PLGA where L signifies the PLA unit 
and G represent the PGA unit. 
PLGA has been the most investigated biodegradable polymer to date due to FDA approval 
of PLGA systems, tunability of its molecular weight, and non-toxic degradation products.48 
Typically, a racemic mixture of the D and L-lactic acid forms are used in PLGA.49 The 
optimal ratio of lactic acid to glycolic acid varies based on the application. The degradation 
of the polymer varies directly with the monomer ratio due to the decrease in hydrophobic 
properties of the copolymer associated with increasing the glycolic acid component.3 
PLGA is soluble in a variety organic solvents including acetone, tetrahydrofuran (THF) 
and chlorinated solvents. Notably, however, it is not soluble in water.50  PLGA has been 
used extensively in drug delivery through the synthesis of nanoparticles and has exhibited 
sustained drug release due to a bulk degradation process.50 PLGA has also been used in 
tissue engineering as bone tissue engineered materials and as porous scaffolds for stem cell 
adhesion.51 PLGA has been used as a material for suturing since 1974, with the introduction 
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of a product called Vicryl®. Since then, many PLGA suture materials including Panacryl®, 
Polysorb® and Pusasorb® have entered the market and are in broad commercial use today.3  
The highly tunable mechanical properties of PLGA have made it a favourable a material 
for bone grafting applications. However, its use has been somewhat limited due to low 
osteoinductivity.51 Its application, however, is limited by the low pH produced by the acidic 
degradation products, and its lack of water solubility.52   
1.2.3 PEG 
PEG is multifunctional polyether with a variety of applications in both tissue engineering 
and drug delivery (Figure 1.7). It has been used in number of FDA approved polymer 
systems due to its low toxicity, resistance to protein uptake, and non-immunogenicity.53 
Although PEG itself is not degradable, it is removed from the body through renal and 
hepatic pathways.  PEG is synthesized through a polycondensation reaction of ethylene 
glycol in the presence of an acidic catalyst and can also be polymerized via either an anionic 
or cationic route. The anionic method is preferred as it has proven to offer better control 
over the molecular weight and polydispersity.54 PEG is available commercially in a variety 
of molecular weights, ranging from tetra(ethylene glycol) to PEG with a molar mass of 
100,000 g/mol. Relative to other synthetic biomedical polymers, PEG is unique with 
respect to its high solubility in both water and organic solvents. Consequently, PEG is one 
of the most widely used polymers in biomedical engineering. In drug delivery systems, 
PEG has been used to develop nanoparticles, microparticles, liposomes, dendrimers and 
hydrogels. For example, the Gillies lab has used PEG in PCLA-PEG-PCLA thermo-
responsive hydrogels for drug delivery.55-56  
 
Figure 1.7. Chemical structure of PEG. 
The unique properties of PEG have given rise to a chemical process called PEGylation, 
which involves the covalent attachment of PEG to various molecules.57 PEGylation has 
been further explored as a means of enhancing the pharmacokinetics and 
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pharmacodynamics of drug delivery systems by altering the half-life, stability, and 
degradation rate of the drug itself.58  Commercially, numerous biomedical products use 
PEG. PEGylated liposomal nanocarriers for cancer therapy, specifically a product under 
the name of Doxil®,	 is one of the most notable commercial uses for PEG. Doxil® was 
introduced in 1995 as the first FDA approved nanodrug and remains a widely used 
therapeutic today.59 PEG has also been used in tissue engineering to develop a variety of 
scaffolds. However, its applications have been limited by the fact that cells do not adhere 
well to the surface of PEG. This poor adherence is due to the specific hydrogen bonding 
and hydration properties PEG, which is a non-natural molecule in the context of biological 
systems.60 As such, PEG surfaces have been modified with RGD peptide sequences or used 
in conjunction with natural polymers such as gelatin.10, 61 This has improved cellular 
adherence to the scaffolds and allowed for greater cell proliferation and migration.11   
1.2.4 Poly(ester amide)s (PEA)s 
While the aforementioned polymers such as PLA and PLGA have been commonly been 
used in biomedical applications, they exhibit drawbacks such as acidic degradation 
products and lack of structural and mechanical tunability.62-63 PEAs (Figure 1.8) present 
an exciting new class of polymers which possess unique advantages owing to the presence 
of both esters and amides bonds in their backbones.64 There has been increasing interest in 
PEAs due their ability to undergo enzymatic and non-enzymatic hydrolytic degradation at 
physiological pH, as well as their ability to be tuned and functionalized.63, 65 The 
degradation products of PEAs can be tailored to result in non-toxic metabolites, and the 
incorporation of amino acids into PEAs has been shown to increase cellular adhesion in 
three-dimensional cell culture systems.66  
 
Figure 1.8. Example of a PEA structure where the PEA is derived from amino acids. 
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Various types of PEAs have been synthesized for applications including drug delivery and 
tissue engineering. Chu and colleagues have synthesized and studied unsaturated PEAs that 
incorporated an alkene bond in the backbone.66-70 These unsaturated PEAs were then 
photochemically crosslinked at a 1:1 ratio with PEG diacrylate to create hydrogels. 
Although unsaturated PEAs offer great potential for post-polymerization modification, 
they pose inherent difficulties during synthesis due to unwanted crosslinking of the alkene 
group. Chu’s group has also developed an arginine-containing PEA in which di-p-
nitrophenyl succinate served as a linker between monomers based on L-arginine and L-
phenylalanine. The molecular weights of these molecule were found to be 15-25 kg/mol 
and sufficient for the formation of nanoparticles.71  
Work in the Gillies and Mequanint groups focused on preparing functional PEAs that 
incorporated diols, dicarboxylic acids and amino acids.65, 72-74 The incorporation of these 
non-toxic monomers led to the synthesis of several PEAs for biomedical applications. For 
example, the Gillies and Mequanint groups studied the adhesion and proliferation of human 
coronary artery smooth muscle cell (HCASMC) on PEAs coatings and three-dimensional 
scaffolds prepared by electrospinning.72 More recently, they prepared scaffolds with 
pendant carboxylic acid groups through a pressure differential and particulate leaching 
method which resulted in good porosity and microstructure. Through an oil in water 
emulsification evaporation process, the Gillies group used PEAs to create polymeric drug 
delivery vehicles that were used to encapsulate hydrophobic drugs such as celecoxib for 
intra-articular drug delivery.74 The PEAs used in these drug delivery systems were 
synthesised through an interfacial polymerization. The monomer synthesis and interfacial 
polymerization are illustrated in Schemes and 1.1 and 1.2, respectively. The monomer 
synthesis and interfacial polymerization produced PEAs with high molecular weights 
around 60 kg/mol and the resulting drug loaded microparticle systems possessed a hydrated 
Young’s modulus of 0.83 MPa.74 
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Scheme 1.1.  Synthesis of p-toluenesulfonic acid salt monomer.74 
 
Scheme 1.2. Synthesis of PEA through interfacial polymerization.74 
Most recently, the Gillies and Flynn groups used water-soluble PEAs to create hydrogels 
for the encapsulation of adipose derived stromal cells (ASC).75 Water soluble PEAs were 
synthesized through the incorporation of PEG diamine and a bifunctional monomer derived 
from phenylalanine (Phe) and alanine (Ala), copolymerized with a fumarate monomer as 
seen in Scheme 1.3. The PEA system was then successfully photo-crosslinked into a 
hydrogel using UV light and Irgacure 2959 as the initiator. The Phe-PEA had a modulus 
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of 106 ± 11 kPa and Ala-PEA had a modulus of 44 ± 13 kPa, which are similar to variety 
of soft tissue, including the bladder and muscle tissue.75 When assessing the biological 
properties of the system, it was concluded that the hydrogels provided a supportive 
platform for ASC adipogenesis.76  
 
Scheme 1.3. Synthesis of water-soluble PEAs as reported by Liang et al.76 Reproduced 
with permissions from reference 76. Copyright 2020, Elsevier. 
1.3 Hydrogels in biomedical engineering  
Since the first commercial use of hydrogels in 1962 in contact lenses, hydrogels have been 
used in both clinical and academic settings.77-78 Hydrogels are three-dimensional polymer 
networks capable of absorbing large amounts of water or biological fluids. They have been 
used extensively in tissue engineering on the basis that their high water content, porosity, 
and mechanical properties mimic that of native soft tissue.79  
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Hydrogels can be classified into two main categories: reversible gels (physical gels) and 
permanent gels (chemical hydrogels).77 The differentiating factor is the molecular forces 
between the polymer chains. Reversable hydrogels are gels in which the polymer chains 
form a network through secondary forces such as ionic bonding, hydrogen bonding or 
hydrophobic/hydrophilic interactions. Through changes in the environment, such as pH or 
temperature, it is possible for the chain entanglement of these gels to revert back to a linear 
like polymer state. Conversely, permanent gels are prepared through covalent crosslinking 
methods, and are unable to revert to their original state once formed. A more detailed 
discussion of various crosslinking methods will be provided later in this section.  
To properly design hydrogels, it is important to understand their performance in an aqueous 
environment, such as the human body. Upon injection or implantation of a hydrogel in 
vivo, it undergoes rapid swelling until it has reached equilibrium with its surrounding 
environment. During this phase, the pore size of the hydrogel increases, allowing for 
diffusion to occur. The second step of the hydrogel’s life cycle is swelling induced 
degradation. This phase is initiated by degradation of the polymer networks, which results 
in a loss of the elastic restorative force of the hydrogel and further swelling.80 Finally, as 
the hydrogel continues to swell, it will undergo an increased rate of bulk degradation via 
enzymatic and hydrolytic pathways.81 Innovations in polymer science have greatly 
improved the chemical and mechanical properties of hydrogels, resulting in enhanced in 
vivo control. This has allowed for the commercial application of hydrogels in products such 
as contact lenses and wound dressings.  
1.3.1 Hydrogels in drug delivery  
Hydrogels are used extensively in drug delivery for their controlled release, tunable 
properties and effective encapsulation of various therapeutics. Maintenance of the 
concentration of a drug within the effective therapeutic window requires repeated 
administration and high doses of the therapeutic when conventional oral administration is 
used (Figure 1.9).82 This may result in the drug concentration reaching a toxic dose, 
resulting in harmful side effects. A variety of drug delivery systems, including 
nanoparticles, liposomes and hydrogels, have been developed to address this issue and 
improve targeted drug delivery.83  
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Figure 1.9. Therapeutic window of pharmaceuticals representing the desired therapeutic 
range in which pharmaceuticals are effective.82 
Along with their ability to simulate soft tissue, hydrogels provide an attractive delivery 
material as they can be synthesized in aqueous environments, eliminating the possibility of 
denaturing encapsulated therapeutics when exposing them to organic solvents. Hydrogels 
can be delivered a number of ways, including surgical implantation and local needle 
injection.84 The route of administration is highly dependent upon the desired application 
and the chemical composition of the hydrogel. Hydrogels for drug delivery can be further 
categorized, based on their size, into either macroscopic gels, microgels or nanogels. 
Currently, the most widely used systems are macroscopic hydrogels, which are on the scale 
of millimetres to centimeters.85 While some success has been seen with surgical 
implantation of hydrogels, a recent focus on the development of in situ gelling hydrogels 
has sought to minimize the need for potentially harmful, invasive procedures.86 In situ 
gelling hydrogels are injected into the body as a liquid, at which point a sol-gel transition 
occurs, forming the final gel structure. For in situ gelling systems, it is ideal that the 
gelation is initiated ex vivo and occurs slowly. This will result in greater control over the 
shape of the hydrogel in vivo, and the subsequent release profile.87  
There are several ways to control the release profile of a drug from the hydrogel. One 
method is to control the rate of degradation of the hydrogel. As the network degrades, the 
mesh size is increased, as is the rate of drug release (Figure 1.10). To change the rate of 
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degradation, the chemical composition of the gel can be altered.88 For example, much of 
the degradation of hydrogels occurs via hydrolysis. Thus, the incorporation of amide bonds, 
as opposed to hydrolytically degradable ester bonds, can effectively slow degradation.74 
Additionally, drug release can be controlled by incorporating stimuli-responsive units, 
which respond to changes in temperature or pH.55-56  
 
Figure 1.10. Hydrogel mesh size and subsequent release properties.85 Reproduced with 
permissions from reference 85. Copyright 2016, Springer Nature. 
Alginate is a common stimuli-responsive polymer which forms a tightly bound gel in 
acidic conditions, such as those found in the stomach, but becomes deprotonated and 
swells once upon reaching a neutral pH.89 There are also a variety of different ways in 
which the drug itself can be incorporated into the hydrogel system. These methods 
include covalent linkages, electrostatic interactions and hydrophobic associations.85 
Finally, once the hydrogel has delivered the desired therapeutic, it is important that it 
degrades into components that are non-toxic and easily cleared by the host organism. 
Overall, hydrogels have been shown to be very effective as drug delivery systems and 
will continue to allow researchers to develop controllable treatment options.  
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1.3.2 Hydrogels in tissue engineering  
Along with their frequent use in drug delivery applications, hydrogels are also widely used 
in the field of tissue engineering. This field of research is largely focused on restoring, 
enhancing or preserving tissue function. Fundamentally, this is accomplished by seeding 
cells into a scaffold that mimics the ECM, in which they are able to proliferate and 
differentiate into the desired lineage. The primary goal of the scaffold is to deliver cells to 
the target site within the body, while providing an environment in which the cells can 
proliferate. To do that, the scaffold must encourage cell-biomaterial interactions, promote 
cellular adhesion, allow for the transport of essential cell nutrients, and elicit a minimal 
host response.2, 90 Figure 1.11  illustrates the life cycle of a hydrogel from the harvesting 
of the cells to the hydrogel injection.  
 
 
Figure 1.11. Life cycle of hydrogel scaffolds for tissue engineering.91 Figure reproduced 
from Bone Research open access journal. 
In most cases, it is ideal that the scaffold degrades over time to allow for integration with 
the host tissue. The biodegradation of the scaffold must be carefully controlled to allow for 
the full maturation of the encapsulated cells before degradation is complete. The alteration 
of the components within the scaffolds allows for controlled degradation.65, 72, 92 
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Additionally, the synthesis components and crosslinking method must be carefully selected 
to ensure that toxic components, such as organic solvents, unreacted monomers and 
emulsifiers, are entirely removed before it is used in vivo. Purification of the scaffold can 
be completed through techniques such as extensive washing or dialysis.   
Along with consideration of chemical properties, there must be a great deal of emphasis on 
the mechanical properties of the hydrogel. One of the important factors affecting the 
mechanical characteristics of the scaffold is the pore size and extent of porosity. The 
incorporation of pores within the network of the hydrogel also increases the surface to 
volume ratio, allowing for cellular adherence and various mass transportation phenomena 
to occur. The ideal size of the pore depends on the application. 5-15 μm pores are optimal 
for fibroblast tissue growth, and 20-125 μm pores are optimal for the growth of mammalian 
skin cells.9 It is also important that the scaffold is engineered to mimic the elastic behavior 
of the native tissue. The stiffness of hydrogels can range between 0.5 kPa and 5 MPa due 
to their highly tunable nature.93  Hydrogels can therefore provide the mechanical cues 
necessary to mimic many different host tissues. To promote cellular adherence within the 
scaffold, the physicochemical and topographical compositions must be considered. The 
most effective approaches rely on the incorporation of RGD peptide sequences, which can 
be found in natural polymers such as gelatin, insulin and fibronectin. By incorporating both 
synthetic and natural polymer materials, the mechanical and biological cues of the scaffold 
can be optimized.  
Given their tissue-like properties, hydrogels have also been widely used as cell delivery 
platforms. Current cell therapies often rely on suspending cells in a saline solution and 
directly injecting the cells. This has resulted in low retention of cells at their desired 
location, which is largely attributed to mechanical washout of cells.85 The migration of 
cells away from their target location greatly decreases their potential therapeutic 
effectiveness. Thus, to limit cellular migration and increase their commercial potential, 
hydrogels have been used to deliver cells in vivo. Encapsulating cells within hydrogels also 
has the additional benefit of acting as a barrier between the cells and the host environment. 
This encapsulation protects the cells from macrophage attack, while still allowing for 
signaling and the entrance of metabolic molecules through the semi-permeable membrane. 
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Furthermore, hydrogels allow for the controlled and targeted delivery of cells. However, 
hydrogels are designed differently based on their application, such as controlled drug 
versus cellular delivery. Due to the micron scale of cells and their delicate nature, cellular 
delivery hydrogels often entrap cells within microgels. Microgels allow for greater inward 
diffusion of oxygen and various nutrients while allowing for outward diffusion of cellular 
waste, all of which lead to increased cell viability.94  
1.4 Hydrogel crosslinking methods  
Hydrogels vary by their composition, application and method of crosslinking. Crosslinking 
allows the polymer chains that make up the gel to form a network in which water and the 
therapeutic can be retained. Physically crosslinked gels can be categorized into those 
assembled through ionic/electrostatic interactions, hydrogen bonding, crystallization, 
hydrophobic interactions based on lower and upper critical solution temperatures 
(LCST/UCST) and ultrasonication. Chemically crosslinked gels can be gelled via photo-
polymerization, Michael type addition, Diels-Alder reactions, Schiff base formation, and 
other chemical reactions.95  
1.4.1 Physical crosslinking methods  
Physically crosslinked gels have received increasing interest due to their ability crosslink 
without harmful crosslinking agents, thereby potentially reducing cytotoxicity. Currently, 
the most widely used physically crosslinked systems rely on ionic interactions.96 These 
gels are often composed of two different components with opposite charges. Alginate is a 
naturally occurring anionic polysaccharide commonly used to create physically gelled 
systems. Alginate is crosslinked through the addition of divalent cations such as barium, 
calcium and magnesium.23, 97 Alginate gels are synthesized at room temperature and 
physiological pH, making them ideal for cell encapsulation. Chitosan is a natural polymer 
that has been used to form physically crosslinked gels via electrostatic interaction between 
its cationic amino groups and other anionically charged species, such as chondroitin sulfate 
and polyphosphoric acid.31 The properties of ionically gelled hydrogel systems can be 
altered by varying the charge density of the polymers, and the ratio of incorporated 
polymers. The ability of physically crosslinked systems to self-heal following exposure to 
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high stress environments, alongside reduced cytotoxicity, has increased the use case of 
these systems in wound healing applications.98  
Recent advances in polymer science have led to polymer gelation through thermal 
induction, based on LCST/UCST.99 These systems use amphiphilic graft copolymers 
which form micelles in an aqueous environment.100 The micelle contains a hydrophobic 
core surrounded by hydrophilic polymer components. Thermo-responsive polymers are 
often dispersed or soluble when below their LCST. When the temperature of a solution is 
raised above the LCST, regions of the polymer that were previously water-soluble become 
aggregated resulting in gel formation.95 The Gillies group has used this phenomenon to 
create thermally-responsive hydrogels for drug delivery by using block co-polymers 
consisting of PEG, L-lactide and ε-caprolactone.55-56 Although physically crosslinked 
systems can be effective for certain applications, the bond strength is limited, resulting in 
weak interactions between the molecular chains and increased degradability of the 
hydrogel.  
1.4.2 Chemical crosslinking  
To increase the mechanical integrity of hydrogels, a variety of chemically-induced 
crosslinked methods have been explored. The majority of these crosslinking systems rely 
on the generation of free radicals and the use of unsaturated alkene groups to induce 
covalent bond formation. One of the commonly used crosslinking systems in the formation 
of biomedical hydrogels is photo-crosslinking.101 In most cases, photo-crosslinking uses 
highly reactive, unsaturated vinyl groups, which are able to from covalent bonds in the 
presence of light and a radical photoinitiator. Photo-crosslinked hydrogels benefit from 
rapid gelation times and tunable crosslinking density under relatively mild conditions.102 
There are a variety of different commercially available photoinitiators that have been 
proven cytocompatible and functional at different wavelengths.  
For biomedical applications, water soluble photo-initiators that respond to UV light, such 
as Irgacure 2959 (Figure 1.12) , are most frequently used.95 A type 1 photo-initiator relies 
on the specific wavelength of light to degrade the molecule into two radicals. Radical 
generation occurs when the Irgacure 2959 is exposed to light at a wavelength of 365 nm. 
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This prevents premature crosslinking by ambient visible light.103 To limit cellular toxicity, 
the duration of crosslinking should not exceed five minutes, and low concentrations 
between 0.1-0.01 w/v of photo-initiator should be used.104 While UV curing methods have 
been widely used, the DNA damage caused by UV radiation remains a concern.9, 105 As a 
result, recent advances in photo-crosslinking methods have relied on visible light for 
crosslinking. While these methods are still in their infancy, they provide a safer alternative 
to UV crosslinking and will likely be the preferred crosslinking method moving forward.106  
 
Figure 1.12. Chemical structure of photoinitiator Irgacure 2959.104 
In addition to UV crosslinking, chemically-initiated free radical crosslinking is a 
commonly used method in hydrogel formation. A frequently used free radical gelation 
method employs the redox system involving ammonium persulfate (APS) and N,N,N,N-
tetramethylethylenediamine (TEMED), as illustrated in (Figure 1.13) where it is used to 
make hydrogels crosslinked with methacrylamide and maleic acid.107 Crosslinking is 
initiated by the degradation of APS and subsequent radical formation on carbon adjacent 
to vinyl group. The APS and TEMED crosslinking mechanism has been used in hydrogel 
systems for its relatively low toxicity, rapid reaction rate and favourable in situ gelation 
conditions.108  
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Figure 1.13. APS/TEMED Crosslinking of maleic acid and methacrylamide functional 
units.107 Figure reproduced from Acta Chemica Iasi open access journal. 
Crosslinking via nucleophilic Michael addition involving a radical initiator and crosslinker 
is another commonly used technique. A Michael addition is a reaction in which a Michael 
donor (a nucleophile) attacks a Michael acceptor (activated electrophilic alkene) and forms 
a covalent bond.95 This reaction is favorable as it can occur under mild conditions, 
incorporates a variety of different crosslinking agents, and allows for in situ gelation. For 
example, thiols and amines have also been used in Michael addition reactions to bond with 
the vinyl groups present in polymers based on itaconic acid (Figure 1.14).109 Thiols can be 
found in a variety of proteins and amino acids, such as cystine, making them ideal 
candidates for non-toxic crosslinking methods.110 Careful consideration must be taken 
when using thiols for Michael addition crosslinking as conditions must be optimized to 
avoid disulfide bridge formation. Hydrophilic thiol crosslinking molecules can be 
synthesised by using bifunctional PEG as a base molecule and adding thiol groups to the 
ends of the polymer chain.95 The disulfide PEG linkers can be synthesized from a variety 
of different PEG lengths, offering a large degree of tunability. Michael addition of 
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polymers containing vinyl groups allows for facile and rapid crosslinking with relativity 
low toxicity.   
 
Figure 1.14. Michael addition of various functional handles on polymers derived from 
itaconic acid.109 Reproduced with permissions from reference 109. Copyright 2010, 
Royal Society of Chemistry.  
N-hydroxysuccinimide esters (NHS esters) have been used extensively in coupling and 
crosslinking reactions involving protein and amino acid chemistry.111 NHS esters react 
with primary amines under physiological conditions to form amide bonds. N-(3-
dimethylaminopropyl)-N′-ethylcarbodiimide (EDC), a water soluble coupling reagent, has 
also been used in conjunction with NHS to allow for carboxylic acid coupling with amine 
functional groups.112  The hydrolysis rate of NHS esters lends it to a wide range of 
biological applications. The hydrolysis rate at pH 7.4 falls within the range of several hours 
(h), and varies directly with pH.113 Figure 1.15 illustrates the amide bond formation with 
NHS esters. NHS esters are highly reactive and crosslinking can occur within a timeframe 
ranging from minutes to h. For the crosslinking of linear polymer systems containing 
primary amines, NHS ester crosslinking is a viable option and typically occurs in buffered 
system such as PBS.114 To achieve successful crosslinking for hydrogels, a bifunctional 
water-soluble linker that incorporates NHS esters on its terminal groups can be synthesized. 
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Although NHS esters have been used extensively for protein conjugation, their applications 
in hydrogel crosslinking are limited by poor stability and challenging chemistry.115 This is 
especially true for polymers that have undergone a tert-Butyloxycarbonyl (BOC) 
deprotection, as the cationic amine must be deprotonated at higher pH to successfully form 
crosslinks. As discussed, there are variety of methods that can be used to crosslink polymer 
systems. The optimal method must be selected based on the desired application, 
crosslinking time, possible cytotoxic effects, and scalability.  
 
Figure 1.15. NHS ester crosslinking mechanism.116 
1.5 Itaconic acid (IA) 
While different synthetic polymers can be used for biomedical applications, small 
molecules derived from biological and sustainable sources have gained attention in recent 
years. The shift is largely reflective of public demand for sustainable alternatives and the 
potential depletion of fossil fuels. IA is a bio-derived monomer which can be obtained from 
fungus and algae, and bears structural similarity to commonly used monomers. Dimethyl 
itaconate (DMI) (Figure 1.16) is a methylated version of IA that is commonly used in 
polymerization reactions. 117 It is currently produced on an industrial scale via fermentation 
of Aspergillus terreus.118 IA contains an alkene group and two carboxylic acid groups, 
which can be modified to optimize the chemical and mechanical properties of the material. 
The a,b-unsaturated carbonyl group of IA bears structural similarity to that of methacrylic 
and acrylic acid, which have widespread use in dental materials and elastomers.119 
Furthermore, IA offers material tunability via modification of the unsaturated alkene group 
either post-polymerization or post-scaffold fabrication. This reactivity potentially allows 
for the introduction of drugs, cell-adhesive materials, and cell-signalling ligands, as well 
as crosslinking. IA is also well suited for biomedical applications due its anti-inflammatory 
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properties, expressed via activation of transcription factor Nrf and modulation of type 1 
interferons.120-121 IA has also been shown to regulate macrophage function and has the 
potential to regulate tumor progression.122  
 
Figure 1.16. Structure of dimethyl itaconate (DMI). 
While promising, synthesis of polyesters derived from IA for biomedical applications has 
been limited thus far. This is largely due to the difficulty in synthesis caused by premature 
crosslinking via reaction of the unsaturated alkene as well as intramolecular 
rearrangements of IA (Figure 1.17).118, 123 Nevertheless, polyesters derived from IA are 
particularly attractive due to their biological activity and ability to degrade by enzymatic 
and non-enzymatic pathways.118, 124 
 
Figure 1.17. a) Possible regioisomerization of DMI. b) Potential crosslinking that can 
occur with trace radicals present.123 
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While the research remains in its early stages, several approaches for the synthesis of linear 
polymers derived from IA have been studied. However, few have been able to keep the 
unsaturated alkene intact while synthesizing polymers with molecular weights above 10 
kg/mol. Winkler et al. synthesized polyesters via a polycondensation reaction between IA 
and various diols (Scheme 1.4). The reaction was catalysed by tin(II) ethylhexanoate, and 
incorporated the radical inhibitor 4-methoyxy phenol (MEHQ) to prevent premature 
crosslinking. The reaction was conducted for 6 h in a nitrogen environment at 120 °C to 
encourage the generation of low molecular weight oligomers. Subsequently, high vacuum 
was applied for 12 h to remove the methanol and promote the formation of polyesters with 
Mn values between 8-14 kg/mol.125 This a promising polymerization method for the 
synthesis of IA derived polyesters as the alkene remained intact. 
 
 
Scheme 1.4. Synthesis of polyesters derived from IA.125 
To synthesize ultra-high molecular weight polyesters containing IA, Ly and colleagues 
used an acyclic diene metathesis (ADMET) approach. An ADMET is a reaction catalyzed 
by a ruthenium catalyst and involves a reordering of the alkene bonds present. To conduct 
this reaction with IA, the group first synthesized a monomer consisting of IA functionalized 
with long carbon chains having terminal vinyl groups (Scheme 1.5). The synthesis of the 
monomer was conducted with a Dean-Stark apparatus using p-toluenesulfonic acid as a 
catalyst and hydroquinone as a radical inhibitor. Subsequent polymers were then generated 
in a nitrogen atmosphere through the addition of a Grubbs-I catalyst with a reflux in CHCl2 
for 10 h. The Grubbs-I catalyst was selected due to its relatively low reactivity, which was 
hypothesized to contribute to the selective reactivity of the terminal vinyl groups, rather 
than the alkene group present on IA. This specific polymerization method produced 
polymers with Mn values between 19,000 and 45,000 kg/mol.  
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Scheme 1.5. Synthesis of high molecular weight polyesters derived from IA via ADMET 
polymerization using Grubbs-I catalyst.124 
While itaconic acid has been used to synthesize linear polyesters, the process is 
complicated by the highly reactive vinyl group. Trotta and colleagues aimed to reduce the 
reactivity by altering the olefin to improve the molar masses of the resulting polymers and 
prevent premature crosslinking. The Diels-Alder reaction was used to produce a 
nonconjugated alkene which was less reactive.125-126 As illustrated in Scheme 1.6, the 
reaction was conducted using isoprene at elevated temperatures in a nitrogen purged 
environment, with scandium triflate Sc(OTf)3 as a catalyst. Trotta noted that subsequent 
polymerization reactions with the nonconjugated IA derivative produced higher yields and 
improved conversion.126  
 
Scheme 1.6. Synthesis of non-conjugated alkene functional group derived from IA.126 
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1.6 Motivation for thesis  
The objective of this thesis was to develop new water-soluble synthetic polymers for the 
preparation of hydrogels for applications in tissue engineering and drug delivery. The 
Gillies group recently reported hydrogels composed of water-soluble and crosslinkable 
PEAs prepared from PEG, Phe or Ala, and 1,4-butanediol or 1,8-octanediol. They were 
used successfully for the encapsulation of adipose derived stem cells (ASCs).76 However, 
it is desirable to enable further tuning of the mechanical properties of these materials, and 
to enhance cell attachment, proliferation, and differentiation.  
It was hypothesized that through the incorporation of biologically-derived components 
such as Asp and IA, it would be possible to reduce the PEG content, and also to create 
water-soluble polymers with pendent functional handles that could be used to conjugate 
drugs and/or biological signals such as peptides to achieve enhanced cell attachment, 
proliferation, and differentiation compared to our previously reported hydrogels.76 In this 
context, Chapter 2 describes the synthesis of amine- and alkene-functionalized polyesters. 
These polyesters contain both natural and synthetic components and are synthesized using 
a variety of different PEG lengths. Furthermore, they are functionalized with different 
anhydrides including methacrylic anhydride, maleic anhydride, and itaconic anhydride 
with the aim of being able to crosslink them to form hydrogels. The reactivities of these 
different derivatives in free radical crosslinking is described and the properties of the 
resulting gels are studied. Finally, the hydrogels are used to encapsulate ASCs and the cell 
viability is assessed. Chapter 3 describes the development of new water-soluble polyesters 
containing IA within their backbones. Given the anti-inflammatory and tumor regulation 
properties of naturally derived IA, the possibility for them to break down, releasing IA, is 
of interest for biomedical applications. Additionally, the polymers are synthesized to 
incorporate amine functional groups which can be used for further crosslinking or the 
attachment of cell-signaling or cell-adhesive molecules. Hydrogel crosslinking is 
investigated and the properties of the resulting gels are studied.  Chapter 4 describes the 
conclusions of this thesis and offers suggestions for future work.    
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2 Functionalized Water-Soluble Polyesters for Potential 
Tissue Engineering Applications  
 
2.1 Introduction  
Over the past 20 years, advances in polymer science and our understanding of biological 
systems have allowed for innovations in the field of tissue engineering. Polymers play an 
important role in tissue engineering by providing scaffolds to support cells, thereby 
mimicking the extracellular matrix (ECM) found in natural tissues.1-2 A variety of natural 
polymers including collagen,3-5 cellulose,6-7 gelatin,8-11 and chitosan12-15 have been used to 
prepare scaffolds. While these polymers assist with cellular adhesion, their isolation from 
natural sources can result in unfavorable batch to batch variability. Furthermore, due to the 
complex structure of naturally occurring biopolymers, the possibility to tune their 
mechanical properties is limited.  
The use of polyesters offers a promising approach to tissue engineering due to their ability 
to degrade hydrolytically or enzymatically via esterase. Currently, synthetic polyesters 
such as poly(L-lactic acid) (PLLA),16-17 poly(propylene fumarate),18-19 poly(butylene 
succinate),20 and poly(ε-caprolactone) (PCL)21 are used to prepare scaffolds.  While 
tunable in terms of chemical structure and mechanical properties, these synthetic polyester 
systems lack the natural components required for cellular adhesion.22-23 The majority of 
polyesters are hydrophobic, requiring scaffold preparation methods such as 
electrospinning, salt leaching, and gelation in non-aqueous solvents. These methods do not 
allow cells to be encapsulated during scaffold preparation, and can result in the presence 
of residual trace chemicals that are harmful upon cell incorporation.17, 24 
To better replicate native tissue, hydrogels have been used extensively in tissue 
engineering. Hydrogels benefit from their physiologically relevant water content, porous 
structure, and tunable mechanical properties.25, 7 Furthermore, systems that gel in situ allow 
for the encapsulation cells during hydrogel formation, improving cell viability and 
delivery.  For cells to adequately adhere to the hydrogel scaffold, natural components such 
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as arginine-glycine-aspartate, (RGD) peptide sequences and amino acids have been 
incorporated into the hydrogel.26-27 
 Recent research in polymer science has led to the emergence synthetic polymers that 
incorporate natural components that can be recognized by biological systems.28-32 These 
examples have largely relied on the incorporation L-amino acids into polymer systems due 
to their role as building blocks in natural peptides and proteins.  Examples of synthetic 
poly(amino acids) that have been employed include poly(L-lysine), 33 poly(L-ornithine), 34 
and poly(L-arginine).35 However, poly(amino acids) have several drawbacks including 
their slow degradation rates and their synthesis from N-carboxyanhydrides, which are 
expensive and unstable.29, 36-38 As such, polymers that incorporate both synthetic and 
natural components have gained interest to improve functionality while still benefitting 
from of the incorporation of natural components. For example, poly(ester amide)s (PEAs) 
are characterized by the presence of both esters and amides bonds.39 Increasing interest in 
PEAs is largely owed to their ability to undergo enzymatic and hydrolytic degradation at 
physiological pH, as well as that to be tuned and functionalized.22, 29 The Chu and Gillies 
groups have synthesized PEAs that are water soluble and incorporate functional alkene 
groups within the polymer system. 31, 40 These polymer systems have incorporated amino 
acids including L-phenylalanine41, L-alanine41 and L-arginine42 into the backbone of the 
polymers. PEG was incorporated to enhance water solubility. However, these PEAs are 
limited by complex synthesis procedures and the production of toxic synthesis byproducts 
such as p-nitrophenol. Recent advancements in the facile melt polycondensation process 
have allowed for the synthesis of polyesters containing L-glutamic acid and L-Aspartic 
acid (Asp).28 The amino acids were incorporated via transesterification reactions with 
various synthetic diols. The protected amino groups were then used for further 
functionalization to produce amyloid hierarchical helical fibrils.  
The objective of the research outlined in this chapter was to build on Asp-containing 
polyesters28 by incorporating two chemical advancements to facilitate their application in 
hydrogels (Figure 2.1). First, with respect to the aforementioned Asp-containing 
polyesters,28 we incorporated PEG diols instead of alkane diols to impart water solubility. 
Second, pendant functional groups were incorporated for crosslinking, allowing for 
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hydrogel formation. To achieve this, we assessed the introduction of three different 
functional moieties to the pendent amines of the polymers. Methacrylate functional units 
were investigated for their ability to undergo rapid gelation via means of free radical 
crosslinking. 14, 43  Maleic acid was also investigated due to the presence of an alkene group, 
which enables crosslinking, as well as a carboxyl acid group, which can be subsequently 
coupled to bioactive components via further reactions.44-46 Finally, the introduction of 
itaconic acid was investigated. Like maleic acid, its unsaturated alkene allows for 
crosslinking, but its reactivity is higher than that of internal alkenes. 47 Itaconic acid 
pendent groups also provide carboxylic acids for further conjugation chemistry. 
Furthermore, itaconic acid is commercially derived from Aspergillus terreus and 
Aspergillus itaconicus, making it a bio-sourced unit.48-50 I describe here the synthesis of 
new Asp-containing polyesters, their characterization, and progress towards the 
preparation of hydrogels from these polymers.  
 
Figure 2.1. General structure of a water-soluble Asp-containing polyester with pendent 
crosslinkable groups. 
2.2 Experimental  
2.2.1 General experimental details  
BOC-L-Aspartic acid dimethyl ester monomer was synthesized as previously reported.28 
Poly(ethylene glycol) (PEG) diol with a molar mass of 600 g/mol (PEG 600) was 
purchased from TCI America (Portland, OR, USA).  PEG diol with molar mass of 1500 
g/mol (PEG 1500) and maleic anhydride were purchased from Alfa Aesar (Haverhill, MA, 
USA). Itaconic anhydride and potassium persulfate (KPS) were purchased from Acros 
Organics (Waltham, MA, USA). Pyridine, triethylamine (NEt3) and N,N-
dimethylacetamide (DMA) were purchased from Caledon Laboratories Inc. (Georgetown, 
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Canada). Methacrylic anhydride was purchased from Sigma Aldrich (St. Louis, MO, 
USA). Phosphate buffered saline (PBS) at pH 7.4 and N,N,N’,N’-
tetramethylethylenediamine were purchased from Fisher Scientific. All other chemicals 
were purchased from Fisher Scientific (Waltham, MA, USA).  All chemicals were and used 
as received unless otherwise noted. PEG 600 and PEG 1500 were dried via two azeotropic 
distillations with toluene. CH2Cl2, DMA, pyridine, and NEt3 were distilled over CaH2 
under a nitrogen atmosphere to remove water. Column chromatography was performed 
using silica gel (0.063– 0.200 mm particle size, 70–230 mesh). 1H and 13C NMR spectra 
were obtained at 400 MHz on a Bruker AvIII HD instrument. Chemical shifts are reported 
in ppm and are calibrated against the residual protonated solvent signals of CDCl3. Size-
exclusion chromatography (SEC) was carried out in N,N-Dimethylformamide (DMF) 
containing 0.1 M LiBr and 1% (v/v) NEt3 at 85 °C using a Waters 515 HPLC pump, a 
Waters In-Line Degasser AF, two PLgel mixed D 5μm (300 x 1.5 mm) columns connected 
to a corresponding PLgel guard column, and a Wyatt Optilab Rex RI detector operating at 
658 nm. Samples were prepared at ~5 mg/mL in the eluent and filtered through a 0.22 μm 
polytetrafluoroethylene (PTFE) syringe filter prior to injection using a 50 μL loop. The 
number average molar mass (Mn), weight average molar mass (Mw), and dispersity (Đ) 
were determined relative to poly(methyl methacrylate) (PMMA) standards. Samples were 
run at a flow rate of 1 mL/min for 30 min. Dialysis was performed using Spectra/Por 6 
dialysis tubing from Spectrum Laboratories (Rancho Dominguez, CA, USA) with 
molecular weight cutoff (MWCO) of 10 kg/mol or 3.5 kg/mol. Salt exchange dialysis was 
conducted in a solution of 1 M NaCl for 3 h followed by distilled water for 4 h. Fourier 
transform infrared (FT-IR) spectra were obtained using a PerkinElmer FT-IR Spectrum 
Two instrument with attenuated total reflectance (ATR) sampling.  
2.2.2 Polymer synthesis  
Synthesis of Asp-PEG-1500-BOC and representative procedure for the 
polymerization. BOC-L-Aspartic acid methyl ester monomer (1.00 g, 3.80 mmol, 1.00 
equiv.) and dried PEG 1500 diol (5.74 g, 3.80 mmol, 1.00 equiv.) were added to a flame 
dried 100 mL two neck round bottom flask. The flask was heated to 100 °C and the excess 
moisture was removed by purging with nitrogen and subsequent evacuation with vacuum 
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under constant stirring. The purging and evacuation was repeated three times, followed by 
the addition of Ti(OBu)4 (12.0 mg, 0.038 mmol, 1.0 mol%). The reaction mixture was then 
heated to 120 °C and stirred under nitrogen for 4 h, during which oligomers were generated. 
The reaction was then slowly switched to high vacuum and heated for an additional 3 h. 
The reaction mixture then was cooled to room temperature, diluted in CH2Cl2 (20 mL), and 
precipitated in cold Et2O (200 mL) to afford 4.97 g of polymer. Yield = 76%  1H NMR 
(CDCl3, 400 MHz): δ 5.60-5.54 (m, 1H), 4.63-4.52 (m, 1H), 4.35 – 4.21 (m, 4H), 3.77–
3.50 (m, 132H), 3.09–2.89 (m, 1H), 2.88–2.82 (m, 1H), 1.45 (s, 9H).  13C NMR (CDCl3, 
100 MHz): δ 170.9, 170.7, 155.3, 72.5, 68.9, 68.8, 64.6, 64.0, 61.7, 51.9, 49.9, 36.8, 28.3. 
FT-IR: 2865, 1717, 1639, 1532, 848 cm-1. SEC: Mn = 12.4 kg/mol, Mw = 22.5 kg/mol, Đ 
= 1.8. 
Synthesis of Asp-PEG-600-BOC. This polymer was synthesized by the same procedure 
as Asp-PEG-1500-BOC except that the following quantities were used: L-Aspartic methyl 
ester monomer (5.00 g, 19.0 mmol, 1.00 equiv.); PEG 600 diol (11.4 g, 19.0 mmol, 1.00 
equiv.); Ti(OBu)4  (64.7 mg, 0.190 mmol, 1.00 mol%). The final product was centrifuged 
at 2800 g. The supernatant was decanted, and the precipitated product was collected to 
afford 11.1 g of polymer. Yield = 76%. 1H NMR (CDCl3, 400 MHz): δ 5.60-5.52 (m, 1H), 
4.65-4.55 (m, 1H), 4.38-4.19 (m, 4H), 3.77-3.55 (m, 54H), 3.05-2.93 (m, 1H), 2.92-2.79 
(m, 1H), 1.44 (s, 9H). 13C NMR (CDCl3, 100 MHz): δ 170.9, 155.3, 79.9, 68.8, 68.7,63.9, 
49.9, 36.7, 28.3, 28.2. FT-IR: 2962, 1784, 1636, 1520 cm-1. SEC: Mn = 12.2 kg/mol, Mw = 
29.4. kg/mol, Đ = 2.4.   
Synthesis of Asp-PEG-1500 and representative procedure for the removal of the BOC 
protecting group. Asp-PEG-1500-BOC (5.00 g, 2.92 mmol, 1.00 equiv.) was dissolved 
in dry CH2Cl2 (20.0 mL) and cooled to 0 °C.  Trifluoracetic acid (TFA) (5.00 mL, 29.5 
mmol, 10 equiv.) was added dropwise to the reaction. The reaction was warmed to room 
temperature and stirred for 2 h. The solvent was then removed under reduced pressure and 
the product was precipitated in cold Et2O (100 mL). The deprotected polymer was then 
dried overnight in vacuo to afford 4.76 g of polymer. Yield = 95%. 1H NMR (CDCl3, 400 
MHz): δ 4.54-4.37 (m, 1H), 4.35–4.12 (m, 4H), 3.78–3.35 (m, 54H), 3.29–3.15 (m, 1H), 
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3.14–2.78 (m, 1H). 13C NMR (CDCl3, 100 MHz): 170.9, 170.6, 72.5, 70.2, 68.7, 64.4, 63.9, 
61.5, 49.9, 36.7, 28.2. SEC: Mn = 8.46 kg/mol, Mw = 24.1 kg/mol, Đ = 2.85. 
Synthesis of Asp-PEG-600. The deprotection of PEG-600-Asp-BOC was carried out 
using the same procedure for that of Asp-PEG-1500, except that PEG-600-Asp-BOC 
(5.00 g, 6.16 mmol, 20.2 equiv.), CH2Cl2 (20.0 mL) and TFA (10.0 mL, 59.0 mmol) were 
used to afford 4.67 g of polymer. Yield = 94%. 1H NMR (CDCl3, 400 MHz): δ 4.56-4.47 
(m, 1H), 4.43–4.18 (m, 4H), 3.83–3.56 (m, 54H), 3.29–3.18 (m, 1H), 3.07–2.87 (m, 1H). 
13C NMR (CDCl3, 100 MHz): δ 170.5, 169.4,168.4, 70.2, 65.3, 64.7, 64.3, 64.1, 60.0 50.3, 
49.7, 34.2. FT-IR: 2975, 1783 cm-1. SEC: Mn = 8.61 kg/mol, Mw = 15.4 kg/mol, Đ = 1.79.  
Functionalization of the polymer with methacrylic anhydride (ME), synthesis of Asp-
PEG-1500-ME. Asp-PEG-1500 (2.00 g, 1.16 mmol, 1.00 equiv.) was added to a 250 mL 
flame dried round bottom flask. DMA (60 mL) was added and the polymer was fully 
dissolved. Dry NEt3 (8.14 ml, 0.0580 mol, 50.0 equiv.) was then added dropwise to the 
solution and stirring continued for 10 min. Methacrylic anhydride (0.693 ml, 4.67 mmol, 
4.00 equiv.), was then added dropwise to the solution. The flask was then submerged in an 
oil bath and heated to 70 °C and stirred for 10 h under nitrogen. The flask was cooled to 
room temperature and excess NEt3 was removed. The polymer solution was then dialyzed 
against 500 mL of acetone. After 24 h, the acetone was replaced with water and salt 
exchange dialysis was conducted. The polymer was then lyophilized to afford 1.41 of 
polymer. Yield = 72%. 1H NMR (CDCl3, 400 MHz): δ 6.94-6.83 (m, 0.60H), 6.35-6.30 
(m, 0.22H), 6.14 (s, 0.23H), 5.78 (s, 0.94H), 5.60-5.57 (m, 0.27H), 5.40 (s, 0.67H), 4.95–
4.85 (m, 0.78H), 4.41-4.18 (m, 4.05H), 3.85–3.50 (m, 132H), 3.15–3.03 (m, 1.00H), 2.99–
2.88 (m, 1.23H), 2.06–1.93 (m, 2.95H).  13C NMR (CDCl3, 100 MHz): δ 170.9, 170.6, 
167.8, 139.3, 125.7, 120.5, 69.1, 68.8, 68.7, 64.8, 64.0, 63.8, 61.6, 48.6, 36.1, 18.4. FT-IR: 
2884, 1738, 1670, 1628, 1520 cm-1. SEC: Mn = 8.38 kg/mol, Mw = 15.1 kg/mol, Đ = 1.80. 
Synthesis of Asp-PEG-600-ME. Synthesis of Asp-PEG-600-ME was carried out using 
the same procedure as for Asp-PEG-1500-ME except that Asp-PEG-600 (2.00 g, 2.46 
mmol, 1.00 equiv.), NEt3 (17.1 ml, 0.123 mol, 50.0 equiv.), and methacrylic anhydride 
(1.45 ml, 9.85 mmol, 4.00 equiv.) were used to afford 1.37 g of polymer. Yield = 72%. 1H 
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NMR (CDCl3, 400 MHz): δ 6.9-6.8 (m, 0.57H), 6.35-6.29 (m, 0.17H), 6.14 (s, 0.17H)  5.78 
(s, 0.93H), 5.60-5.57(m, 0.20H), 5.40 (s, 0.60H), 4.97-4.79 (m, 0.74H),  4.41-4.18 (m, 
4.45H), 3.85-3.59 (m, 54H), 3.15-3.05 (m, 0.84H), 2.99-2.90 (m, 1.01H), 2.04-1.94 (m, 
2.95H). 13C NMR (CDCl3, 100 MHz): δ 171.1, 170.5, 170.3, 170.1, 167.9, 139.6, 136.2, 
134.7, 126.2, 120.4, 93.1, 82.1, 64.8, 64.7, 64.2, 64.1, 52.1, 49.4, 49.3, 39.9, 36.2, 35.8, 
24.8, 24.5, 18.8, 18.4, 18.1, 14.9, 14.8. FT-IR: 2863, 1731, 1671, 1524 cm-1. SEC: Mn = 
10.2 kg/mol, Mw = 17.9 kg/mol, Đ = 1.79. 
Functionalization of the polymer with maleic anhydride (MA), synthesis of Asp-PEG-
1500-MA. Asp-PEG-1500 (2.00 g, 1.16 mmol, 1.00 equiv.) was added to a 250 mL flame 
dried round bottom flask. Dry DMA (60 mL) was added and the polymer was fully 
dissolved. Dry NEt3 (8.14 ml, 58.3 mmol, 50.0 equiv.), was then added dropwise to the 
solution and stirring continued for 10 minutes. Dry pyridine (2.35 ml, 29.2 mmol, 25.0 
equiv.) was then added to the mixture and stirring was continued for 5 min. Maleic 
anhydride (0.458 g, 4.67 mmol, 4.00 equiv.) was then added dropwise to the solution. The 
flask was then left to stir at room temperature for 10 h under nitrogen. Excess pyridine and 
NEt3 was removed and the solution was dialyzed against 500 mL of acetone. After 24 h, 
the acetone was replaced with water and salt exchange dialysis was conducted. The 
polymer was then lyophilized to afford 1.71 g of polymer. Yield = 78%. 1H NMR (CDCl3, 
400 MHz): δ 6.60–6.18 (m, 2.34H), 5.02–4.86 (m, 0.92H), 4.48–4.19 (m, 4.64H), 3.90–
3.50 (m, 132H), 3.16–2.96 (m, 2.23H). 13C NMR (CDCl3, 100 MHz): δ 169.9, 169.2, 166.1, 
164.8, 135.7, 133.7, 131.3, 127.6, 72.5, 70.8, 70.5, 70.4, 70.3, 70.1, 68.7, 68.6, 68.5, 65.0, 
64.7, 63.8,49.6, 35.7. FT-IR: 2883, 1733, 1635, 1558 cm-1. SEC: Mn = 9.34 kg/mol, Mw = 
20.7 kg/mol, Đ = 2.21   
Synthesis of Asp-PEG-600-MA. Synthesis of Asp-PEG-600-MA was carried out using 
the same procedure as for Asp-PEG-1500-MA except that Asp-PEG-600 (2.00 g, 2.46 
mmol, 1.00 equiv.), NEt3 (17.1 ml, 0.123 mol, 50.0 equiv.), pyridine (4.96 ml, 61.0 mmol, 
25.0 equiv.), and maleic anhydride (0.966 g, 9.84 mmol, 4.00 equiv.) were used to afford 
1.43 g of polymer. Yield = 72%. 1H NMR (CDCl3, 400 MHz): δ 6.61-6.23 (m, 2.10H), 
4.99-4.88 (m, 1.04H), 4.45-4.21 (m, 4.57H), 3.77-3.60 (m, 54H), 3.15-3.00 (m, 2.18H). 
13C NMR (CDCl3, 100 MHz): δ 170.4, 170.2, 166.9, 165.1, 162.7, 133.0, 130.1, 71.2, 68.5, 
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64.8, 64.2, 49.1, 46.0, 40.6, 40.4, 40.2, 39.7, 39.5, 39.3, 36.2, 35.8, 31.2. FT-IR: 2865, 
1723, 1635, 1559 cm-1. SEC: Mn = 7.19 kg/mol, Mw = 33.3 kg/mol, Đ = 4.63.  
Functionalization of the polymer with itaconic acid (IA), synthesis of Asp-PEG-1500-
IA. Asp-PEG-1500 (2.00 g, 1.16 mmol, 1.00 equiv.) was added to a 250 mL flame dried 
round bottom flask. Dry DMA (60 mL) was added and the polymer was fully dissolved. 
Dry NEt3 (1.63 ml, 11.7 mmol, 10.0 equiv.) was then added dropwise to the solution and 
stirring continued for 10 min. Dry pyridine (4.71 ml, 59.0 mol, 50.0 equiv.) was then added 
to the mixture and stirring continued for 5 min. Itaconic anhydride (0.327 g, 2.92 mmol, 
2.50 equiv.), was then added to the solution dropwise. The flask was then left to stir at 
room temperature for 10 h under nitrogen. Excess pyridine and NEt3 was removed and the 
solution was then dialyzed against 500 mL acetone. After 24 h, the acetone was replaced 
with water and salt exchange dialysis was conducted. The polymer was then lyophilized to 
afford 1.58 g of polymer. Yield = 68%. 1H NMR (CDCl3, 400 MHz): δ 6.50 (s, 0.56H), 
5.86 (s, 0.75H), 4.93-4.85 (m, 0.82H), 4.40–4.21 (m, 3.83H), 3.81–3.53 (m, 132H), 3.12–
2.83 (m, 2.25H). 13C NMR (CDCl3, 100 MHz): δ 162.7, 70.2, 65.5 45.9, 36.4, 31.4, 31.2 
15.0. FT-IR: 2884, 1733, 1635, 1558 cm-1. SEC: Mn = 6.19 kg/mol, Mw = 30.1 kg/mol, Đ 
= 4.86 
Synthesis of Asp-PEG-600-IA. Synthesis of Asp-PEG-600-IA was carried out using the 
same procedure as for Asp-PEG-1500-IA except that Asp-PEG-600 (2.00 g, 2.46 mmol, 
1.00 equiv.), NEt3 (3.43 ml, 24.0 mmol, 10.0 equiv.), pyridine (10.1 ml, 61.0 mmol, 50.0 
equiv.), and itaconic anhydride (0.690 g, 6.16 mmol, 2.50 equiv.) were used to afford 1.32 
g of polymer. Yield = 66%. 1H NMR (CDCl3, 400 MHz): δ 6.52 (s, 0.74H), 5.83 (s, 0.88H), 
4.93-4.85 (m, 0.96H), 4.36-4.17 (m, 4.84H), 3.77-3.50 (m, 54H), 3.15-2.99 (m, 2.27H). 
13C NMR (CDCl3, 100 MHz): δ 169.7, 162.6, 162.2, 161.9, 161.6, 121.1, 118.1, 115.2, 
112.3, 70.4, 70.0, 68.7, 45.8, 36.5, 31.4. FT-IR: 2871, 1733, 1640,1525 cm-1.  SEC: Mn = 
3.72 kg/mol, Mw = 8.78 kg/mol, Đ = 2.36.  
2.2.3 Hydrogel preparation and characterization 
Hydrogel preparation. Hydrogels were prepared by dissolving the polymers in PBS at 
pH 7.4 to achieve solutions with polymer concentrations of 10 and 20 % w/v. Stock 
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solutions of KPS and TEMED, were prepared at concentrations of 100 mM. Gels were 
formed by adding KPS and TEMED sequentially achieving a final molar concentration of 
10 mmol or 20 mmol of each reagent depending on the desired formulation. The solutions 
were drawn up in 1 ml syringe and incubated at 37 °C for 20 min.  
Gel content and equilibrium water content (EWC). Immediately following 
crosslinking, the initial mass (mi) of the hydrogel was measured and the theoretical mass 
(mt) was calculated based on the amount of polymer used in the gel preparation. The 
hydrogels were then swelled in PBS for 24 h, and the swollen mass (ms) was measured. To 
remove un-crosslinked material and salts, the hydrogels were submerged in distilled water 
for 3 h. They were then frozen in liquid nitrogen, lyophilized, and their dry masses (md) 
were measured. The experiments were completed in triplicate for each hydrogel 
formulation. The gel content and EWC were calculated using the equations (1) and (2) 
respectively.  
!"#	%&'("'( = !!!" *	100%                                    (1) 
./0 = !#"!!!# *	100%                                          (2) 
Mass swelling ratio. The initially prepared hydrogels were weighed and their masses (mi) 
were recorded. The hydrogels were then submerged in PBS at 37 °C and swollen for 24 h, 
upon which no further mass gain was achieved. The swollen mass (ms) was then recorded. 
The mass swelling ratio was calculated using the following equation:  
1233	34"##5'6	72(5&	 = !#"!$!$ *	100%                                          (3) 
SEM micrographs. Crosslinked hydrogels were swelled in PBS, followed by rinsing the 
surface of the hydrogel 3 times with water then lyophilized. SEM micrographs were 
obtained by mounting the lyophilized scaffolds on carbon taped aluminum stubs and 
sputtered with gold at a rate of 5 nm/min for 4 min (Hummer-6 sputtering system, Anatech, 
Union City, California). SEM was performed on a Hitachi S-3400N instrument at a voltage 
of 10 kV (Hitachi, Toyko, Japan).  
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Compression testing. The compressive modulus was determined using a CellScale 
Microsquisher system (Waterloo, ON, Canada). In brief, a micro-scale parallel-plate 
compression configuration fitted with a 558.8 μm diameter cantilever was used to test the 
hydrogels. The hydrogels were placed in a Dulbecco's phosphate-buffered saline (D-PBS) 
fluid bath at 37 ℃ and the cantilever was lowered until the upper compression plate made 
contact with the hydrogel. The hydrogels were compressed to a total strain of 20% at a rate 
of 0.6%/s for a total of 6 cycles. The compressive modulus was determined from the slope 
of the linear region of the stress–strain curve between 10 and 15% strain. 
Cell encapsulation and viability. ACSs were isolated and cultured as previously 
reported,31 in compliance with the protocol approved by the Human Research Ethics Board 
(Western University Protocol #105426). Hydrogels were prepared by dissolving polymers 
Asp-PEG-600-ME and Asp-PEG-1500-ME in PBS to achieve a final polymer solution 
concentration of 10% w/v. ASCs were suspended in proliferation medium at a 
concentration of 7.5 × 106 cells/mL and combined with the polymer solution for hydrogel 
encapsulation. The final solution volume contained 80% polymer solution and 20% ASC 
suspension by volume. Solutions of KPS and TEMED were then added sequentially to 
afford a final concentration of 10 mM of each reagent. Solutions were the drawn up in a 1 
mL syringe and incubated at 37 °C for 20 min. Immediately after crosslinking, the 
hydrogels were cut into 50 μL volume disks, each containing ~ 1.25 × 105 cells, transferred 
into 12-well inserts (Greiner Bio-one, Germany), and cultured in proliferation medium at 
37 °C with 5% CO2. Viability of the encapsulated ASCs in the Asp-PEG-600-ME and 
Asp-PEG-1500-ME hydrogels was assessed at 24 and 72 h after encapsulation using the 
LIVE/ DEAD® Viability/Cytotoxicity Kit for mammalian cells (Cat. # L-3224; Life 
Technologies Inc., Burlington, ON, Canada). During preparation, the hydrogels were 
rinsed twice in PBS before incubation in 1× staining solution for 45 min at 37 °C. Next, 
the hydrogels were rinsed two times with PBS before imaging using a Zeiss LSM 800 
confocal microscope (Zeiss Canada, Toronto, ON, Canada). The complete cross-sectional 
area of each hydrogel was imaged at 5× magnification and mosaic images were generated 
using the Zen software (Zeiss Canada). A total of 10 layers, separated by 40 μm, were 
imaged for each hydrogel sample.  
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2.3 Results and discussion  
2.3.1 Polymer synthesis  
BOC protected aspartic dimethyl ester (Asp-BOC-DME)  was synthesized as previously 
reported.28 Asp-PEG-BOC polyesters were synthesized through a transesterification 
reaction at 120 °C and under reduced pressure (Scheme 2.1). The reaction was catalyzed 
by Ti(OBu)4  and conducted under a nitrogen environment for 4 h. It was then switched to 
a reduced pressure environment for 3 h to complete the removal of methanol and promote 
the transesterification reaction. Unlike previous polyesters that incorporated Asp,28 the 
system was made water soluble with the use of PEG as the diol. Two different molar masses 
of PEG were used, with one having a molar mass of 600 g/mol, and one having a molar 
mass of 1500 g/mol, providing the BOC-protected polymers Asp-PEG-600-BOC and 
Asp-PEG-1500-BOC respectively. To prevent possible undesired crosslinking caused by 
the removal of the BOC group and subsequent reaction of the primary amine on Asp, the 
temperature of the reaction and time spent under reduced pressure were controlled. 
Reaction temperatures exceeding 120 °C or durations in excess of 3 h under vacuum 
resulted in crosslinking. An equal ratio of 1:1 Asp to PEG was required to obtain high 
molar mass as other ratios would lead to termination once the limiting monomer was used 
up.  
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Scheme 2.1. Synthesis and functionalization of water-soluble polyesters. 
Asp-PEG-600-BOC and Asp-PEG-1500-BOC were characterized by SEC, NMR 
spectroscopy, and IR spectroscopy. The Mn values for both polymers were about 12 kg/mol 
with Đ values of 1.83 and 2.41 (Table 2.1) and their distributions were monomodal (Figure 
2.2). In the 1H NMR spectra, the peaks between 4.32 to 4.24 ppm correspond to the -CH2- 
protons on the PEG, adjacent to the esters, while the peak corresponding to the other 
protons on PEG are at 3.70 ppm (Figure 2.3a, Figure A2.1-A2.2). The incorporation of Asp 
was confirmed by peaks at 3.1 - 2.8 ppm, which correspond to the -CH2- unit from the β 
carbon of Asp. The -CH- unit from the α carbon of Asp is represented by a peak at 4.6 
ppm, while the peak corresponding to the -NH- proton is at 5.57 ppm. The BOC protecting 
group is characterized by the peak at 1.47 ppm, which corresponds to the -CH3 protons on 
the tert-butyl group. The Asp-PEG-600-BOC and Asp-PEG-1500-BOC polymers were 
differentiated by the integrations of the PEG peaks at 3.70 ppm, which were 54 and 132 
respectively (Figure A2.1-A2.2). FT-IR spectroscopy was also used to confirm the 
successful polymer synthesis. The presence of the PEG alkyl ether backbone, ester and 
carbamate bonds within the polymer are evidenced by the C-H stretch at 2869, the C=O 
stretches at 1717 and 1636 cm-1, and the NH bend at 1520 cm-1 respectively (Figure 2.4a, 
Figure A2.21).  
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Table 2.1. Molar masses of Asp-PEG-BOC and Asp-PEG polymers, as determined by 
SEC.  
Polymer  Mn (kg/mole)  Đ 
Asp-PEG-600-BOC  12.2 2.41 
Asp-PEG-1500-BOC  12.1 1.83 
Asp-PEG-600 8.61 1.79 
Asp-PEG-1500 8.46 2.85 
Asp-PEG-1500-ME 8.38 1.80 
Asp-PEG-600-ME 10.2 1.76 
 
Asp-PEG-1500-MA 9.34 2.07 
Asp-PEG-600-MA  7.12 4.63 
Asp-PEG-1500-IA 6.18 4.87 
Asp-PEG-600-IA 3.72 2.36 
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Figure 2.2. SEC traces of Asp-PEG-600-BOC, Asp-PEG-1500-BOC, Asp-PEG-600 
and Asp-PEG-1500.  
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Figure 2.3. 1H NMR spectra of a) Asp-PEG-600-BOC, b) Asp-PEG-600 showing the 
removal of BOC group, as evidenced by the disappearance of the peak at 1.47 ppm in 
Asp-PEG-600.   
 
 
Figure 2.4. FTIR spectra of protected a) Asp-PEG-600-BOC, and deprotected b) Asp-
PEG-600 showing the appearance of N–H stretch peaks between 2780–2552 cm-1, 
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corresponding to the ammonium trifluoracetic acid salts, and disappearance of the 
carbamate C=O stretch and N–H bend after removal of the BOC group in Asp-PEG-600.  
Removal of the BOC groups from the polymers was achieved using 4:1 dry CH2Cl2:TFA 
volume-volume ratio v/v. Successful deprotection was verified using 1H NMR 
spectroscopy, based on the removal of the peak at 1.47 ppm corresponding to the -CH3 
moieties of the BOC group (Figure 2.3). The removal of the -NH- peak at 4.6 ppm further 
confirmed the removal of the BOC group. FT-IR further validated the removal of the BOC 
protecting group due to absence of the C=O carbamate stretch at 1636 cm-1 and NH bend 
at 1520, which were both present on the protected polymers (Figure 2.4). In addition, peaks 
corresponding to N-H stretches of the pendent ammonium groups appeared between 2552 
and 2780 cm-1. SEC was used to confirm that significant degradation of the polymer did 
not occur during the deprotection. With respect to the Asp-PEG-BOC polymers, the 
average retention time of the deprotected polymers slightly increased, which is likely due 
to interactions of the polymers within the columns of the SEC instrument, along with 
possibly a small amount of backbone cleavage.  
2.3.2 Polymer functionalization with crosslinkable moieties  
Methacrylic anhydride (ME) - ME was reacted with Asp-PEG-600 and Asp-PEG-1500 
at a 4:1 molar ratio relative to pendent amines on the polymers to afford the functionalized 
polymers Asp-PEG-600-ME and Asp-PEG-1500-ME (Scheme 2.1). NEt3 was used as a 
non-nucleophilic base to deprotonate the cationic ammonium trifluoroacetate salts that 
were isolated from the BOC deprotections, allowing the amines to react. The reactions 
were conducted in DMA as the solvent. It was determined that heating the reaction to 70 
°C yielded higher degrees of functionalization than 25 °C and 120 °C. Molar ratios of 6, 8 
and 10 equivalents of anhydride were also tested but did not lead to higher degrees of 
functionalization. Pyridine was also investigated as a catalyst but resulted in premature 
crosslinking of the polymer system. The degree of functionalization was determined using 
1H NMR spectroscopy by setting the integrations of the PEG peaks at 54 for Asp-PEG-
600 and 132 for Asp-PEG-1500. The peaks located at 5.70 and 5.41 ppm were then 
integrated and the % functionalization was calculated as the (integral/1.0) x 100% (Figure 
2.5a, Figure A2.5-A2.6). Peaks were also observed at 6.14 and 5.58 ppm which we attribute 
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to rotational isomers about the methacrylamide bond which were included in the % 
functionalization calculation. Further confirmation of rotational isomers was observed by 
the peak at 6.35-6.30 ppm which corresponds to the -NH- unit on the carbamate bond. A 
peak at 2.0 ppm corresponding to the methyl group -CH3 of the methacrylate was also 
observed. Based on these analyses, the % functionalization was 95 % for Asp-PEG-600-
ME and > 95 % for Asp-PEG-1500-ME (Table 2.2).  The FT-IR spectra were also 
consistent with the reported functionalized polymer system as noted by the C=C stretch at 
1671 cm-1, the carbamate C=O stretch at 1628 cm-1, the N-H bend at 1525 cm-1 and C-H 
bend from the alkene at 853 cm-1 (Figure 2.6). The molar masses and dispersities measured 
by SEC for Asp-PEG-600-ME and Asp-PEG-1500-ME were relatively similar to those 
of the starting polymers. 
 
Figure 2.5. 1H NMR spectra of a) Asp-PEG-600-ME, b) Asp-PEG-600-MA, c) Asp-
PEG-600-IA showing the addition of ME, MA and IA anhydride species respectively. 
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Successful incorporation is noted by the peaks between 6.7 – 5.3 ppm which correspond 
to protons upon the alkene group of the anhydride species.   
 
 
 
 
 
Table 2.2. Amine conversions for the functionalization of the polymers with ME, MA, 
and IA. 
 % Functionalization with the anhydride 
 Asp-PEG-600 Asp-PEG-1500 
ME 95 > 95 
MA > 95 > 95 
IA 81 65 
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Figure 2.6. FT-IR spectra illustrating successful functionalization of anhydrides for 
polymers (a) Asp-PEG-600-ME, (b) Asp-PEG-600-MA, (c) Asp-PEG-600-IA. The 
spectra show the C-H alkane stretch between 2866-2870 cm-1, the C=C alkene stretch 
between 1674-1671 cm-1, the C=O ester stretch between 1733-1722 cm-1, the C=O 
carbamate stretch between 1628-1635 cm-1, the N-H bend between 1520-1557 cm-1, and 
the C-H alkene bend between 853-843 cm-1. 
Maleic anhydride (MA) - Functionalization of the polymers with MA led to greater than 
95% conversion when 4 equivalents of MA, as well as 50 equivalents of NEt3 and 25 
equivalents of pyridine relative to the pendent amines were used (Table 2.2). The absence 
of either NEt3 or pyridine resulted in incomplete functionalization of the polymer. The 
degree of functionalization of the polymers with MA was determined by 1H NMR 
spectroscopy based on the integrals of the peaks located between 6.61-6.23 ppm 
corresponding internal alkene on MA (Figure 2.5b, Figure A2.7-A2.8). Complete 
functionalization with MA was achieved while conducting the reaction at room 
temperature, whereas heating the reaction to 70 °C resulted in crosslinking of the polymer. 
Reducing the solvent volume of DMA from 60 mL to 30 mL was investigated but resulted 
in crosslinking with 4 molar equivalents of MA. The molar ratios of 6, 8 and 10 equivalents 
of MA were additionally examined but did not lead to improved functionalization, and 10 
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equivalents resulted in crosslinking. FT-IR spectra were consistent with the reported 
functionalized polymer system as noted by the C=C stretch at 1673 cm-1, the carbamate 
C=O stretch at 1634 cm-1, the N-H bend at 1557 cm-1 and C-H bend from the alkene at 850 
cm-1 illustrated in Figure 2.6. The Mn values determined by SEC were lower than those of 
the starting unfunctionalized polymers, especially for Asp-PEG-600-MA, which had an 
Mn of 7.12 kg/mole and Đ of 4.63. The reduced molar mass and increased dispersity are 
likely indicative of the polymer undergoing some degree of crosslinking as there were 
difficulties in dissolving the polymer in DMF for analysis, and likely only the non-
crosslinked lower molar mass fraction dissolved. However, the possibility of some polymer 
degradation during the functionalization conditions cannot be excluded.  
Itaconic anhydride (IA) - IA was incorporated as a functional moiety due to its ability to 
be derived from renewable resources and its highly reactive alkene group. 
Functionalization was achieved by using 4 equivalents of IA, as well as 10 equivalents of 
NEt3 and 50 equivalents of pyridine relative to the pendent amines. The degree of 
functionalization was characterized by the integration values of the peaks corresponding to 
the alkene groups located 6.52 and 5.83 ppm on the 1H NMR spectra (Figure A2.9-A2.10). 
The low intensity of the peaks, corresponding to 65% and 81% for the Asp-PEG-1500-IA 
and Asp-PEG-600-IA polymers respectively (Table 2.2), is likely due to isomerization of 
the highly reactive alkene and potential crosslinking.49-50  The crosslinking hypothesis is 
supported by the broadness of the peaks in the NMR spectrum of Asp-PEG-600-IA (Figure 
2.5c). In addition, the product polymer was difficult to dissolve and only low molar mass 
polymers were detected in the SEC analyses (Table 2.1), suggesting that crosslinked 
species were probably removed through filtration of the samples. Several attempts to 
increase the degree of functionalization and prevent crosslinking involved varying the 
amounts of NEt3 and pyridine, and molar equivalents of IA from 6 to 10. Increasing the 
temperature to 70 °C and 120 °C was also investigated. Additionally, IA was purified 
through a sublimation method reported by Michlovska et al.51 However, with the 
aforementioned purification, variation of molar quantities and temperature, the highest 
degree of functionalization achieved was 81% and crosslinking remained a problem. Aside 
from possible crosslinking, the FT-IR spectra were also consistent with the reported 
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functionalized polymer system as noted by the C=C stretch at 1674 cm-1, the carbamate 
C=O stretch at 1635 cm-1, the N-H bend at 1539 cm-1 and C-H bend from the alkene at 843 
cm-1 (Figure 2.6).  
2.3.3 Hydrogel formation   
Crosslinking of the functionalized polymers was attempted using free radical mechanisms 
initiated by UV light and KPS/TEMED. The UV curing was conducting by incorporating 
the photoinitiator Irgacure 2959 into prepolymer solutions of 10 and 20 wt% at a 
concentration of 0.15 % (m/v). Subsequently, the prepolymer solution was subjected to UV 
light at 365 nm for 4 minutes which has been previously shown to be tolerated by adipose 
derived stem cells (ASCs).2,31 Crosslinking attempts with UV curing failed to produce gels 
in the 4-minute time period. The KPS/TEMED method has also been explored and well 
tolerated biologically.14 Again, formulations containing 10 and 20 wt % polymer were 
prepared. Concentrations of 10 mM and 20 mM of both KPS and TEMED were used. Of 
the ME, MA, and IA-functionalized polymers, only ME-functionalized polymer 
formulations produced gels. These results are likely due to the highly reactive nature of the 
ME group, which is has been used extensively in crosslinking.14, 25, 43, 52 Although complete 
functionalization of Asp-PEG-MA polymers was observed, it is hypothesized that 
crosslinking did not occur due to the lower reactivity of the internal alkene found on MA.47 
The lack of gelation found with Asp-PEG-IA polymers is likely due to reduced reactivity 
of IA when compared with ME, and possible isomerization that may have occurred with 
IA. Gelation of Asp-PEG-ME polymers was conducted for 20 minutes at 37 °C prior to 
their characterization.  
2.3.4 Hydrogel characterization  
To understand the effects of polymer composition and initiator concentration on the 
resulting hydrogels, they were assessed based on their gel content, equilibrium water 
content (EWC) and mass swelling ratio (Figure 2.7, Table A2.1). Gel content measures the 
mass percentage of polymer incorporated into the network. The data indicate that the Asp-
PEG-600-ME gels tended to have a higher gel content than Asp-PEG-1500-ME (Figure 
2.7a, Table A2.1). The gel content of the Asp-PEG-1500-ME 20 wt%, 10 mM initiator 
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formulation of Asp-PEG-600-ME formulation was very low. It is not obvious why this 
was the case but indicates possibly a mismatch between the high concentration of 
methacrylate groups found with the 20 wt% gels and possibly an insufficient number of 
radicals introduced by 10 mM concentration of KPS/TEMED. High gel content of 99 and 
97% was obtained for Asp-PEG-600-ME and Asp-PEG-1500-ME respectively for the 
formulations containing of 10 wt% of polymer and 10 mM of initiator. The EWC, which 
represents the degree of swelling of the gel to dry mass of the polymer, varied across the 
formulations (Figure 2.7b). The Asp-PEG-600-ME (20 wt% and 20 mM initiator) 
formulation had a significantly lower EWC than all the other gels while PEG-600-ME (20 
wt% and 10 mM initiator) had a significantly higher EWC. The higher EWC for Asp-PEG-
600-ME (20 wt% and 20 mM initiator) correlates with the lower gel content for this 
polymer, due to a lower degree of crosslinking allowing higher swelling with water. There 
were also significantly higher EWCs for Asp-PEG-1500-ME at 10 wt% compared to 20 
wt%, regardless of the initiator concentration. This result was expected as a lower polymer 
concentration should lead to a lower density of crosslinks in the network, allowing more 
swelling and consequently higher EWC. With the exception of Asp-PEG-600-ME (20 
wt%, 10mM initiator), which as previously noted, produced a weakly crosslinked gel, there 
were no significant differences between the swelling of the different gels (Figure 2.7c). 
Based on the high gel content and reduced toxicity found with lower concentrations of 
initiator,14 the Asp-PEG-ME (10 wt%, 10 mM initiator) were selected for further testing.  
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Figure 2.7. a) Gel content of hydrogels, # denotes a statistically significant difference 
compared to Asp-PEG-1500-ME, 10 wt%, 10 mM initiator; b) EWC of hydrogels, # 
denotes a statistically significant difference compared to Asp-PEG-1500-ME, 20 wt%, 
20 mM initiator and ASP-PEG-1500-ME  20 wt%, 10 mM initiator. c) Mass swelling 
ratio of hydrogels. All data were analyzed by two-way ANOVA with a Tukey’s post-hoc 
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comparison of the means (p < 0.05). * denotes statistically significant difference 
compared to all other groups. The experiments were performed in triplicate and the data 
are presented as the mean, with error bars corresponding to the SD. 
The compressive moduli of gels formulated with 10 wt% and with 10 mM of initiator were 
evaluated under unconfined compression on the CellSCale Microsquisher system. The 
Asp-PEG-600-ME gel had a Compressive modulus of 6200 ± 2700 kPa and Asp-PEG-
1500-ME had a Compressive modulus of 9300 ± 3700 kpa (Figure 2.8, Table A2.1). These 
moduli are not significantly different from each other, which aligns with the 
aforementioned similarities between the gel content, EWC and swelling ratio systems at 
concentrations of 10 wt% and 10 mM of initiators. Relative to previously reported 
hydrogels, the compressive moduli are high, indicating that dense networks were 
established, as confirmed by the gel content measurements of > 95%. These moduli are 
similar to those of cartilage.53 
 
Figure 2.8. Comparison of the compressive moduli of Asp-PEG-600-ME and Asp-
PEG-1500-ME measured under unconfined compression. The experiments were 
performed in triplicate and the data are presented as the mean, with error bars 
corresponding to the SD. Data were analyzed by a t-test (p < 0.05). *denotes a 
statistically significant difference between groups. 
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SEM micro-graphs were taken of the Asp-PEG-600-ME and Asp-PEG-1500-ME 
hydrogels prepared at 10 wt% polymer and and 10 mM initiator. As shown in Figure 2.9, 
evidence of the porous structures was observed, which allows for transport of nutrients and 
waste in and out of the hydrogel. However, the structures were collapsed, which can likely 
be attributed to the low glass transition temperature of PEG and its low crystallinity in the 
lyophilized state. 
 
Figure 2.9. SEM micrographs of a) Asp-PEG-600-ME and b) Asp-PEG-1500-ME 
showing their porous structures.  
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2.3.5 Cell viability  
 
Figure 2.10 Viability analysis of ASCs encapsulated in the Asp-PEG-600-ME and Asp-
PEG-1500-ME hydrogels. Representative images of the encapsulated ASCs at a) 24 h 
after encapsulation and b) 72 h after encapsulation displaying the distribution of live 
(green: calcein-AM+) and dead (red: ethidium homodimer-1+) cells. Higher 
magnification images of the boxed regions in each complete hydrogel cross-section (scale 
bar: 500 μm) are shown on the right (scale bar: 50 μm). 
To qualitatively assess the efficacy of the hydrogel scaffolds in supporting adipose derived 
stem cells (ASCs), a cell viability study was conducted. ASCs were encapsulated into 
hydrogels and then assessed at 24 and 72 h post encapsulation through LIVE/DEAD® 
imaging analysis by confocal microscopy (Figure 2.10). The cells remained viable after 72 
h, with a slight loss of cell density at 72 h. These images support the hypothesis that Asp-
PEG-600-ME and Asp-PEG-1500-ME hydrogels can support the viability of ACSs and 
that they have the potential to be used cell encapsulation and delivery strategies. As a next 
step, it will be necessary to quality the percentage of live/dead cells at both time points and 
to assess the densities of cells at each time point for each hydrogel.   
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2.4 Conclusions  
We have demonstrated for the first time the successful synthesis of various Asp-PEG 
water-soluble polyesters functionalized with ME, MA and IA. The polymers were 
synthesized through a transesterification reaction and varied in the length of their PEG 
component. The crosslinking of the different functionalized polymers to form hydrogels 
was investigated. While UV-initiated crosslinking did not lead to hydrogels within an 
acceptable time period to be tolerated by cells, initiation with KPS/TEMED led to 
crosslinking of the ME functionalized polymers. The MA and IA-functionalized polymers 
did not crosslink under these conditions. ME functionalized polymers formulated at 10 
wt% and 10 mM of initiator, had gel content of > 95%, an EWC of 91% and a mass swelling 
ratio of roughly 13%. They were found to have compressive modulus slightly larger than 
that of cartilage.53 The potential of these hydrogels to support the viability of ACSs was 
investigated through a LIVE/DEAD assay. Qualitatively, the cells appeared viable over 72 
h, though further work will be needed to quantitatively assess the percentage of viable cells 
and the change in density of viable cells from 24 to 72 h. Overall, these hydrogels warrant 
further investigation as a potential platform for tissue engineering applications. 
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3 Development of hydrogels composed of functionalized 
itaconic acid-containing polyesters 
3.1 Introduction 
Hydrogels have been used in tissue engineering and drug delivery applications and have 
been effective platforms for mimicking the properties found in native tissue.1-4 Hydrogels 
benefit from their physiologically relevant water content, porous structure, and tunable 
mechanical properties.2, 7 Ideally, the polymers used to prepare hydrogels would be derived 
from sustainable sources.5 Additionally, given the economic uncertainty associated with 
the petroleum industry, there has been a shift towards the use of monomers derived from 
renewable sources.6-7 In recent years, itaconic acid (IA) has proven a promising candidate 
for sustainable polymer synthesis and was deemed one of the top value added chemicals 
from biomass by the US department of energy in 2004.8 IA has garnered further attention 
due to its structural similarity to acrylic and methacrylic acid, which traditionally require 
the use of fossil fuels for production. IA is currently produced on an industrial scale via the 
fermentation of Aspergillus terreus and Aspergillus itaconicus.9 It contains a highly 
reactive unsaturated alkene group and carboxylic acid functional handles that can be used 
in a variety of polymerization and post-polymerization modification reactions. Recent 
findings regarding the macrophage response to IA have increased interest in its use for 
biomedical applications.10 In particular, IA has been shown to possess anti-inflammatory 
properties and to regulate tumor progression.11-12 The anti-inflammatory properties of IA 
are realized via activation of transcription factor Nrf and the subsequent modulation of type 
I interferons. These inherent biological properties, along with the unsaturated alkene unit 
on IA, provide a potential platform for the synthesis of biomedical hydrogels for 
applications in tissue engineering. 
Despite IA’s interesting reactivity and properties, applications of IA-containing polymers 
have been limited due to difficult synthesis procedures.13 IA has been widely used to 
synthesize branched polymers,13-15 but the direct polycondensation of IA has been 
 
78 
challenging, due to its highly reactive alkene undergoing isomerization or radical 
crosslinking at high temperatures.13-14, 16 Polymerization reactions with IA have been 
attempted via enzymatic copolymerization and direct polycondensation with various diols. 
While there have been some successes, these reactions have resulted largely in low 
molecular weight polymers (Mn < 3000 Da). 17-19 Recently, Winkler and colleagues were 
able to successfully synthesize higher molecular weight polyesters through a controlled 
polycondensation method via a tin catalyzed transesterification reaction.16 To limit radical 
crosslinking, 4-methoxyphenol (MEHQ) was used as an inhibitor, and specific reaction 
durations under nitrogen and vacuum were adhered to. This careful control allowed for the 
successful synthesis of polyesters, which are particularly attractive due to their ability to 
degrade via enzymatic and non-enzymatic pathways.13, 20 Radisic and colleagues were able 
to synthesize branched polyesters from IA in a reaction catalyzed by tin(II) ethylhexanoate, 
with triethyl citrate and 1,8 octanediol.15 These bioelastomers were then crosslinked to 
form scaffold supports for cardiac tissue patches.  However, the polymers were 
hydrophobic and water-insoluble and therefore could not be used directly in hydrogel 
formation.  
In addition to incorporating IA, there is also substantial interest in the development of 
synthetic polymers that contain biological recognition moieties.21-25 For example, polymers 
that incorporate arginine-glycine-aspartate, (RGD) peptide sequences or the individual 
amino acids derivatives, have shown to promote cellular adhesion.26-27 27 Examples of 
synthetic poly(amino acids) that have been employed include poly(L-lysine), 28 poly(L-
ornithine), 29 and poly(L-arginine).30 However, poly(amino acids) have several drawbacks 
including their slow degradation rates and their synthesis from N-carboxyanhydrides, 
which are expensive and unstable.22, 31-33 Poly(ester amide)s (PEAs), which are 
characterized by the presence of both esters and amides bonds, have been synthesized as 
alternative natural-synthetic hybrid systhesms.34 Water-soluble PEAs containing amino 
acids, as well as alkene groups for crosslinking have been reported.24, 35 However, these 
PEAs are limited by complex synthesis procedures and the production of toxic synthesis 
byproducts such as p-nitrophenol. Recent advancements in the facile melt 
polycondensation process have allowed for the synthesis of polyesters containing L-
glutamic acid and L-Aspartic acid (Asp).21 The amino acids were first protected with  tert-
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butyloxycarbonyl (BOC) groups and then incorporated via polycondensation reactions 
with various synthetic diols. The subsequent removal of the BOC groups from the polymer 
resulted in the formation of polyesters with pendent amines. These amines could potentially 
be used to conjugate moieties such as RGD or other cell signaling molecules if the polymer 
could be incorporated into hydrogels.  
In chapter 2 of this thesis, the synthesis of water soluble polyesters containing Asp and 
poly(ethylene glycol) (PEG) in the backbone was reported. The pendent amine groups of 
Asp were functionalized with methacrylic anhydride, then the resulting polymers were 
used for hydrogel preparation. The incorporation of IA as a pendent polymerizable group 
was also investigated but did not lead to successful crosslinking. In addition, due to 
functionalization of the pendent amines with the crosslinkers, they would not be available 
for subsequent bioconjugation. Therefore, the goal of the current work was to incorporate 
IA into the backbone instead, while leaving the amine free for onward chemistry. Described 
here is the synthesis of three new polymers composed of poly(ethylene glycol) (PEG) diols 
of varying molar mass, Asp, and IA. Their abilities to form hydrogels through the reaction 
of the backbone IA moieties is also described.  
3.2 Experimental  
3.2.1 General experimental details  
BOC-L-aspartic acid dimethyl ester monomer was synthesized as previously reported.21 
PEG diols with molar masses of 200 g/mol (PEG 200) and 600 g/mol (PEG 600) were 
purchased from TCI America (Portland, OR, USA).  PEG diol with a molar mass of 1500 
g/mol (PEG 1500) was purchased from Alfa Aesar (Haverhill, MA, USA). Potassium 
persulfate (KPS) was purchased from Acros Organics (Waltham, MA, USA). Dimethyl 
itaconic (DMI) and 4-methoxyphenol (MEHQ) was purchased from Sigma Aldrich (St. 
Louis, MO, USA). Phosphate buffered saline (PBS) at pH 7.4 and N,N,N’,N’-
tetramethylethylenediamine were purchased from Fisher Scientific (Waltham, MA, USA).    
All other chemicals were purchased from Fisher Scientific (Waltham, MA, USA).  All 
chemicals were and used as received unless otherwise noted. PEG 200, PEG 600 and PEG 
1500 were dried via two azeotropic distillations with toluene. CH2Cl2 was distilled over 
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CaH2 under a nitrogen atmosphere to remove water. Column chromatography was 
performed using silica gel (0.063– 0.200 mm particle size, 70–230 mesh). 1H and 13C NMR 
spectra were obtained at 400 MHz on a Bruker AvIII HD instrument. Chemical shifts are 
reported in ppm and are calibrated against the residual protonated solvent signals of CDCl3. 
Size-exclusion chromatography (SEC) was carried out in N,N-Dimethylformamide (DMF) 
containing 0.1 M LiBr and 1% (v/v) NEt3 at 85 °C using a Waters 515 HPLC pump, a 
Waters In-Line Degasser AF, two PLgel mixed D 5μm (300 x 1.5 mm) columns connected 
to a corresponding PLgel guard column, and a Wyatt Optilab Rex RI detector operating at 
658 nm. Samples were prepared at ~5 mg/mL in the eluent and filtered through a 0.22 μm 
polytetrafluoroethylene (PTFE) syringe filter prior to injection using a 50 μL loop. The 
number average molar mass (Mn), weight average molar mass (Mw), and dispersity (Đ) 
were determined relative to poly(methyl methacrylate) (PMMA) standards. Samples were 
run at a flow rate of 1 mL/min for 30 min. Dialysis was performed using Spectra/Por 6 
dialysis tubing from Spectrum Laboratories (Rancho Dominguez, CA, USA) with 
molecular weight cutoff (MWCO) of 10 kg/mol or 3.5 kg/mol. Salt exchange dialysis was 
conducted in a solution of 1 M NaCl for 3 h followed by distilled water for 4 h. Fourier 
transform infrared (FT-IR) spectra were obtained using a PerkinElmer FT-IR Spectrum 
Two instrument with attenuated total reflectance (ATR) sampling.  
3.2.2 Polymer synthesis  
Synthesis of IA-PEG-600-Asp-BOC and representative procedure for the 
polymerization. DMI (1.05 g, 6.67 mmol, 0.500 equiv.), BOC-Asp-DME (1.74 g 6.67 
mmol, 0.500 equiv.), dried PEG 600 diol (8.00 g, 13.3 mmol, 1.00, equiv.) and MEHQ 
(0.110 mg, 0.896 mmol, 1 w/w%), were added to a flame dried 100 mL two neck round 
bottom flask. The flask was heated to 100 °C and the excess moisture was removed by 
purging with nitrogen and subsequent evacuation with vacuum under constant stirring. The 
purging and evacuation were repeated three times, followed by the addition of Ti(OBu)4 
(12.0 mg, 0.038 mmol, 1.0 mol%). The reaction mixture was then heated to 120 °C and 
stirred under nitrogen for 4 h, during which oligomers were generated. The reaction was 
then slowly switched to high vacuum and heated for an additional 3 h. The reaction mixture 
then was cooled to room temperature, diluted in CH2Cl2 (20 mL), and precipitated in cold 
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Et2O (200 mL) to afford 8.82 g of polymer. Yield = 73%.  1H NMR (CDCl3, 400 MHz): d  
6.37 (s, 0.31H), 5.76 (s, 0.30H), 5.62-5.52 (m, 0.56H),  4.64-4.54 (m, 0.66 H), 4.39-4.21 
(m, 3.75H), 3.81-3.52 (m, 54H), 3.39 (s, 0.72H), 3.11-2.98 (m, 0.58H), 2.94-2.81 (m, 
0.57H), 1.46 (s, 5.40H). 13C NMR (CDCl3, 100 MHz): δ 170.9, 170.7, 170.6, 166.0, 155.3, 
133.5, 128.7, 72.52, 72.5, 70.6, 70.5, 64.6, 64.0, 61.7, 49.9, 37.4, 28.3. FT-IR: 2953 2867, 
1733, 1717, 1639, 1532, 848 cm-1. SEC: Mn = 8.51 kg/mol, Mw = 26.3 kg/mol, Đ = 3.09 
Synthesis of IA-PEG-1500-Asp-BOC. Synthesis of IA-PEG-1500-Asp-BOC was 
carried out using the same procedure as for IA-PEG-600-Asp-BOC except DMI (0.791 g, 
5.00 mmol, 0.5 equiv.), PEG 1500  (15.0 g, 10.0 mmol, 1.00 equiv.), BOC-Asp-DME (1.31 
g, 5.00 mmol, 0.5 equiv.), MEQH (0.170 g, 1.37 mmol, 1.00 wt %,), and Ti(OBu)4 (0.0340 
g, 0.100 mmol, 1 mol%) were used to afford 13.7 g of polymer. Yield = 76%. 1H NMR 
(CDCl3, 400 MHz): d  6.37 (s, 0.37H), 5.76 (s, 0.39H), 5.62-5.51 (m, 0.31H), 4.66-4.52 
(m, 0.44 H), 4.39-4.21 (m, 3.37H), 3.87-3.57 (m, 132H), 3.39 (s, 0.83H), 3.09-2.99 (m, 
0.45H), 2.95-2.81 (m, 0.55H), 1.46 (s, 3.55H). 13C NMR (CDCl3, 100 MHz): δ 170.8, 
170.6, 170.5, 170.5, 165.9, 155.2, 133.5, 133.4, 128.7, 128.5, 115.9, 114.4 72.6, 70.1, 68.8, 
68.7, 64.5, 64.0, 63.9, 61.4, 61.2, 49.9, 37.4, 36.7, 28.2. FT-IR: 2950, 2876, 1739, 1717, 
1634, 1526, 841 cm-1. SEC: Mn = 10.1 kg/mol, Mw = 29.3 kg/mol, Đ = 2.90.   
Synthesis of IA-PEG-200-Asp-BOC. Synthesis of IA-PEG-200-Asp-BOC was carried 
out using the same procedure as for IA-PEG-600-Asp-BOC except DMI (1.51 g, 9.57 
mmol, 0.5 equiv.), BOC-Asp-DME (2.5 g, 9.57 mmol, 0.5 equiv.), PEG 200 diol (3.82 g, 
0.019 mol, 1.00 equiv.), MEHQ (78.3 mg, 0.63 mmol, 1 wt% to all reactants), and 
Ti(OBu)4 (0.033 g, 0.096 mmol, 1.0 mol%) were used to afford 6.67 g of polymer. Yield 
= 69%.1H NMR (CDCl3, 400 MHz): d  6.38 (s, 0.52H), 5.77 (s, 0.52H), 5.62-5.53 (m, 
0.3H), 4.67-4.53 (m, 0.52 H), 4.39-4.19 (m, 4.50H), 3.81-3.52 (m, 16H), 3.39 (s, 1.04H), 
3.12-2.95 (m, 0.56H), 2.93-2.82 (m, 0.60H), 1.46 (s, 4.72H). 13C NMR (CDCl3, 100 MHz): 
δ 170.9, 170.6, 170.5, 165.9, 133.5, 128.7, 128.5, 115.9, 114.6, 70.5, 64.6, 64.1, 63.9, 53.5, 
49.9, 37.4, 36.7, 28.2.  FT-IR: 2959, 2867, 1735, 1717, 1635, 1500, 858 cm-1. SEC: Mn = 
6.27 kg/mol, Mw = 15.6 kg/mol, Đ = 2.48.   
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Synthesis of IA-PEG-600-Asp and representative procedure for the removal of the 
BOC protecting group.  IA-PEG-600-Asp-BOC (5.00 g, 5.52 mmol, 1.00 equiv) was 
dissolved in dry CH2Cl2 (20.0 mL) and cooled to 0 °C. Trifluoracetic acid (TFA) (10.0 mL, 
23.8 mmol, 23.8 equiv.) was added dropwise to the reaction. The reaction was warmed to 
room temperature and stirred for 2 h. The solvent was then removed under reduced pressure 
and the product was precipitated in cold Et2O (100 mL). The deprotected polymer was then 
dried overnight in vacuo. The polymer was then subjected to a salt exchange dialysis (1 L) 
and finally lyophilized to afford 3.28 g of polymer. Yield = 72%. 1H NMR (CDCl3, 400 
MHz): d  6.37 (s, 0.51H), 5.76 (s, 0.51H), 4.67-4.59 (m, 0.41H), 4.37-4.21 (m, 4.30H), 
3.81-3.59 (m, 54H), 3.38 (s, 1.17H), 3.17-2.97 (m, 0.55H), 2.96-2.83 (m, 0.26H). 13C NMR 
(CDCl3, 100 MHz): δ 170.7, 166.0, 134.2, 129.3, 72.8, 70.3, 70.2, 68.7, 68.6, 68.5, 68.4, 
68.4, 64.5, 64.4, 64.1, 60.7, 41.6 37.4.  FT-IR: 2953 2867, 1733, 1717, 848 cm-1. SEC: Mn 
= 7.31 kg/mol, Mw = 17.7 kg/mol, Đ =2.43.   
IA-PEG-1500-Asp. Synthesis of IA-PEG-1500-Asp was carried out using the same 
procedure as for IA-PEG-600-Asp except that IA-PEG-1500-ASP-BOC (5.00 g, 5.52 
mmol,1.00 equiv.), TFA (10 ml, 0.13 mmol, 47.2 equiv.), and CH2Cl2 (20.0 mL) was used 
to afford 3.87 g of polymer. Yield = 81 %. 1H NMR (CDCl3, 400 MHz): d  6.37 (s, 0.45H), 
5.76 (s, 0.58H), 4.57-4.48 (m, 0.92H), 4.42-4.21 (m, 3.70H), 3.87-3.61 (m, 132H), 3.38 (s, 
0.72H), 3.37-3.15 (m, 0.67H), 3.14-2.85 (m, 0.30H). 13C NMR (CDCl3, 100 MHz): δ 170.6, 
169.5, 165.9, 133.4, 128.7, 72.6, 70.4, 70.3, 70.1, 68.9, 68.7, 68.5, 68.4, 65.2, 64.1, 64.1, 
64.0, 63.9, 61.4, 49.7, 37.4, 34.4. FT-IR: 2950, 2876, 1739, 1717, 841 cm-1.SEC: Mn = 
8.53 kg/mol, Mw = 16.0 kg/mol, Đ =1.88.   
IA-PEG-200-ASP. Synthesis of IA-PEG-200-Asp was carried out using the same 
procedure as for IA-PEG-600-Asp except that IA-PEG-200-ASP-BOC (5.00 g, 9.98 
mmol, 1.00 equiv.), TFA (10.0 ml, 59.0 mmol, 13.2 equiv.), and CH2Cl2 (20.0 mL) were 
used to afford 3.08 g of polymer. Yield = 73%. 1H NMR (CDCl3, 400 MHz): d  6.37 (s, 
0.51H), 5.77 (s, 0.45H), 4.69-4.49 (m, 0.68H), 4.46-4.21 (m, 4.26H), 3.87-3.59 (m, 16H), 
3.39 (s, 1.03H), 3.35-3.21 (m, 0.66H) 3.15-2.89 (m, 0.29H). 13C NMR (CDCl3, 100 MHz): 
δ 170.9, 170.6, 170.5, 165.9, 155.3, 133.5, 128.7, 79.9, 70.5, 70.4, 68.9, 68.8, 68.7, 64.6, 
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64.1, 63.9, 49.9, 37.4, 36.7, 28.2. FT-IR: 2959, 2867, 1735, 1717, 858 cm-1. SEC: Mn = 
6.22 kg/mol, Mw = 10.8 kg/mol, Đ =1.74.   
3.2.3 Hydrogel preparation and characterization  
Hydrogel preparation. Hydrogels were prepared by dissolving the polymers in phosphate 
buffered saline (PBS) at pH 7.4 to achieve solutions with polymer concentrations of 25% 
w/v. Stock solutions of potassium persulfate (KPS) and N,N,N',N'-tetramethylethane-1,2-
diamine (TEMED), were prepared at concentrations of 100 mM. Gels were formed by 
adding KPS and TEMED sequentially achieving a final molar concentration of 10 mmol 
or 20 mmol of each reagent depending on the desired formulation. The solutions were then 
incubated at 37 °C for 20 min.  
Gel content and equilibrium water content (EWC). Immediately following 
crosslinking, the initial mass (mi) of the hydrogel was measured and the theoretical mass 
(mt) was calculated based on the amount of polymer used in the gel preparation. The 
hydrogels were then swelled in PBS for 24 h, and the swollen mass (ms) was measured. To 
remove un-crosslinked material and salts, the hydrogels were submerged in distilled water 
for 3 h. They were then frozen in liquid nitrogen, lyophilized, and their dry masses (md) 
were measured. The experiments were completed in triplicate for each hydrogel 
formulation. The gel content and EWC were calculated using the equations (1) and (2) 
respectively.  
!"#	%&'("'( = !!!" *	100%                                    (1) 
./0 = !#"!!!# *	100%                                          (2) 
Mass swelling ratio. The initially prepared hydrogels were weighed and their masses (mi) 
were recorded. The hydrogels were then submerged in PBS at 37 °C and swollen for 24 h, 
upon which no further mass gain was achieved. The swollen mass (ms) was then recorded. 
The mass swelling ratio was calculated using the following equation:  
1233	34"##5'6	72(5&	 = !#"!$!$ *	100%                                          (3) 
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SEM micrographs. Crosslinked hydrogels were swelled in PBS, followed by rinsing the 
surface of the hydrogel 3 times with water then lyophilized. SEM micrographs were 
obtained by mounting the lyophilized scaffolds on carbon taped aluminum stubs and 
sputtered with gold at a rate of 5 nm/min for 4 min (Hummer-6 sputtering system, Anatech, 
Union City, California). SEM was performed on a Hitachi S-3400N instrument at a voltage 
of 10 kV (Hitachi, Toyko, Japan).  
Compression testing. The compressive modulus was determined using a CellScale 
Microsquisher system (Waterloo, ON, Canada). In brief, a micro-scale parallel-plate 
compression configuration fitted with a 558.8 μm diameter cantilever was used to test the 
hydrogels. The hydrogels were placed in a Dulbecco's phosphate-buffered saline (DPBS) 
fluid bath at 37 ℃ and the cantilever was lowered until the upper compression plate made 
contact with the hydrogel. The hydrogels were compressed to a total strain of 20% at a rate 
of 0.6%/s for a total of 6 cycles. The compressive modulus was determined from the slope 
of the linear region of the stress–strain curve between 10 and 15% strain. 
 
3.3 Results and Discussion  
3.3.1 Polymer synthesis and characterization  
The polymers were synthesized through transesterification of DMI in the presence of PEG 
diols and BOC-Asp-DME at 120 °C under reduced pressure (Figure 3.1). The reaction was 
catalyzed by Ti(OBu)4 and MEHQ was used as a radical inhibitor to prevent undesired 
crosslinking of IA. Three different molar masses of PEG were used including PEG 200, 
PEG 600, and PEG 1500. The reaction was conducted for 4 h under a nitrogen environment 
then a vacuum was applied for 3 h to remove methanol generated during the 
transesterification process. To provide an adequate number of crosslinkable moieties and 
cellular adhesion sites, a ratio of PEG:IA:Asp of 1:0.5:0.5 was used.  
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Scheme 3.1 Synthesis of IA-PEG-Asp polymers. 
Based on SEC, polymers with Mn values greater than 6 kg/mole were obtained for each 
PEG length (Table 3.1). In contrast, previous polymerizations of IA with PEG diols in the 
presence of catalytic amounts of p-toluenesulfonic acid at 120 °C failed to produce 
polymers with Mns greater than 1 kg/mol.13 Winkler and colleges used DMI and 
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hydrophobic diols to synthesize a library of polyesters that were catalyzed by tin(II) 
ethylhexanoate.16 These specific conditions were applied to synthesize IA-PEG polyesters 
and successful synthesis of polyesters with molar mass > 3000 kg/mole was observed. 
However, when BOC-Asp-DME was added to the system in our case, the extended time 
period of 10 h under vacuum resulted in removal of the BOC protecting group and 
subsequent crosslinking. Thus, the reaction times under nitrogen was reduced from 6 h to 
4 h and time under vacuum was reduced to 3 h in the current work. To improve the 
polymerization process, Ti(OBu)4 was compared to tin(II) ethylhexanoate and Ti(OBu)4 
was found give higher molar masses. Both hydroquinone and MEHQ were investigated as 
radical inhibitors with MEHQ being found to more effectively reduce crosslinking. To 
ensure that high molecular weight polyesters were produced, it was essential to 
azeotropically dry the PEG prior to the reaction. Failure to dry PEG resulted in the 
formation of low molar mass systems.  The Mn values for IA-PEG-200-Asp-BOC, IA-
PEG-600-Asp-BOC and IA-PEG-1500-Asp-BOC ranged from 6.27 to 10.1 kg/mole with 
Đ values ranging 2.48 to 3.09. The molar mass distributions of polymers were all 
monomodal (Figure A3.15). The molar mass increased with increasing PEG length, which 
could be expected because a lower degree of polymerization would be required to obtain a 
given molar mass for PEG 1500 compared to the shorter PEGs.  
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Table 3.1. Molar mass data of the various polymers as measured by SEC. 
Polymer  Mn 
(kg/mole)  
Mw (kg/mole) Đ 
IA-PEG-200-Asp-BOC 6.27 15.6 2.48 
IA-PEG-600-Asp-BOC 8.51 26.3 3.09 
IA-PEG-1500-Asp-BOC 10.1 29.3 2.90 
IA-PEG-200-Asp 6.22 10.8 1.74 
IA-PEG-600-Asp 7.31 17.7 2.43 
IA-PEG-1500-Asp 8.53 16.0 1.88 
The structures of the polymers were confirmed by 1H NMR spectroscopy (Figure 3.2, 
Figure A3.1-A3.3.). Peaks corresponding to the protons on the α,β unsaturated alkene of 
IA is observed at at 6.37 and 5.76 ppm. A peak at 3.39 ppm was observed corresponding 
to the -CH2- protons in IA. Peaks between 4.39 to 4.21 ppm correspond to the -CH2- 
protons on the PEG, adjacent to the esters. Two multiplets are observed as the PEG 
terminus can be conjugated to Asp or IA. The peak corresponding to the other protons on 
PEG is at 3.70 ppm. The incorporation of Asp was confirmed by peaks at 3.1- 2.8 ppm, 
which correspond to the β -CH2- groups of Asp. The α -CH- of Asp is represented by a 
peak at 4.6 ppm, while the peak corresponding to the -NH- proton of the Boc is at 5.56 
ppm. The BOC protecting group is also characterized by the presence of a peak at 1.47 
ppm, which corresponds to the -CH3 protons on the tert-butyl group. The IA-PEG-200-
Asp-BOC, IA-PEG-600-Asp-BOC and IA-PEG-1500-Asp-BOC were differentiated by 
the integrations of the PEG peaks at 3.70 ppm, which were 16, 54 and 132 respectively 
(Figure A3.1-A2.3). Based on the integrals of the alkene peaks of IA compared to the β -
CH2- peaks from Asp, the ratio of incorporated IA:Asp was 0.9:1.0 for IA-PEG-200-Asp-
BOC, 0.54:1.0 for IA-PEG-600-Asp-BOC, and 0.78:1.0 for IA-PEG-1500-Asp-BOC, 
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indicating that the Asp monomer was more readily incorporated into the polymer than the 
dimethyl itaconate. 
 
Figure 3.1. 1H NMR spectra of a) IA-PEG-1500-Asp-BOC, b) IA-PEG-1500-Asp, 
showing the presence of Asp, IA, and PEG and removal of BOC group, as evidenced by 
the disappearance of the peak at 1.47 ppm in IA-PEG-1500-Asp.  
FT-IR spectroscopy was also used to confirm the polymer structure (Figure 3.3). There are 
two C-H stretches corresponding to the sp2 alkene C-H groups in IA and the sp3 alkane C-
H in PEG, IA, and Asp. The C-H alkene stretch occurs between 2959-2950 cm-1, while the 
alkane C-H stretch is between 2876-2867 cm-1. The spectra also show that as the PEG 
molar mass increased, the relative intensity of the C-H alkene stretch decreased as the IA 
comprises a lower fraction of the polymer. There are also two different ester bonds that are 
formed in the polymer. The ester formed between PEG and Asp, as well as between PEG 
and one side of the IA is a saturated ester (SE) which has a C=O stretch between 1739-
1733cm-1, while the ester formed between PEG and the other side of IA is an α,β 
unsaturated ester (UE) that has a C=O stretch at 1717 cm-1. The Boc carbamate bonds 
within the polymer are evidenced by the C=O stretch at 1639-1643 cm-1, and the NH bend 
at 1532- 1500 cm-1. Finally, the C-H alkene bend associated with IA is observed between 
858-841 cm-1.  
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Figure 3.2. FT-IR spectra of (a) IA-PEG-200-Asp-BOC, (b) IA-PEG-600-Asp-BOC, 
(c) IA-PEG-1500-Asp-BOC. The spectra show the C-H alkene stretch between 2959-
2950 cm-1, the C-H alkane stretch between 2876-2867 cm-1, the C=O saturated ester (SE) 
stretch between 1739-1733 cm-1, the C=O α,β unsaturated ester (UE) stretch at 1717 cm-1, 
the C=O carbamate stretch between 1639-1635 cm-1, the N-H bend between 1532-1500 
cm-1, and the C-H alkene bend between 858-841 cm-1. 
Removal of the BOC groups from the polymers was achieved using 4:1 dry CH2Cl2:TFA 
(v/v). The TFA anion was then exchanged for a chloride anion in a salt dialysis exchange 
to reduce possibly toxicity associated from the TFA. Successful deprotection was verified 
using 1H NMR spectroscopy, based on the removal of the peak at 1.47 ppm corresponding 
to the -CH3 moieties of the BOC group (Figure 3.2). The removal of the -NH- peak at 4.6 
ppm further confirmed the removal of the BOC group. To avoid potential toxicity 
associated with the trifluoroacetate salts, the deprotected polymers were subjected to a salt 
dialysis exchange in which the trifluoroacetate anion was exchanged for a chloride anion. 
The dialysis also helped to remove trace amounts of radical inhibitor MEHQ. This was 
critical for the formation of hydrogels as crosslinking attempted without salt exchange 
dialysis did result in gelation. SEC was used to confirm that significant degradation of the 
polymer did not occur during the deprotection (Figure 3.4, Table 3.1). With respect to the 
 
90 
IA-PEG-Asp-BOC polymers, the average retention time of the deprotected polymers 
slightly increased, which is likely due to interactions of the polymers within the columns 
of the SEC instrument due to the cationic amines, along with possibly a small amount of 
backbone cleavage during the deprotection or dialysis steps.  
 
Figure 3.3. SEC traces of the IA-PEG-200-Asp, IA-PEG-600-Asp, and IA-PEG-1500-
Asp polymers.  
3.3.2 Hydrogel formation and characterization  
Crosslinking using the IA alkene moieties was first attempted with a UV light-initiated 
radical polymerization method. The photoinitiator Irgacure 2959 was incorporated at a 
concentration of 0.15 m/v% into 25 w/w% solutions of polymer in PBS. Subsequently, the 
solution was subjected to UV light at 365 nm for 4 minutes, which has been previously 
shown to be tolerated by adipose derived stem cells (ASCs).36,24 Crosslinking attempts with 
UV curing failed to produce gels in the 4-minute time period. Therefore, we investigated a 
thermally initiated free radically polymerization method with KPS/TEMED as the initiator 
as this method has also been explored and well tolerated biologically.27 Formulations of 25 
w/w% polymer were prepared in PBS and crosslinking was initiated by adding with 20 
mM of both KPS and TEMED sequentially. The solutions were then drawn up in a 1 mL 
syringe and placed in an incubator at 37 °C for 20 minutes. Of the three deprotected 
formulations attempted, IA-PEG-600-Asp and IA-PEG-1500-Asp produced gels, 
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whereas IA-PEG-200-Asp failed to produce a gel. The lack of gelation found with IA-
PEG-200-Asp is likely due to reduced aqueous solubility as the formulations were 
observed to be cloudly. This low solubility can be attributed to the reduced molar mass of 
PEG and increased concentrations of hydrophobic IA and Asp in the backbone.   
The IA-PEG-600-Asp and IA-PEG-1500-Asp hydrogels were assessed based on their gel 
content, mass swelling ratio and equilibrium water content. Gel content measures the mass 
percentage of polymer incorporated into the network. The gel contents of both polymers 
were relatively low (i.e., less than 50%). This result was not expected, as IA is known to 
be highly reactive. However, it may be explained by the relatively low density of IA units 
in the backbones of the polymers that results from the incorporation of PEG and Asp. The 
gel content of IA-PEG-600-Asp was significantly higher than that of IA-PEG-1500-Asp, 
which can likely be attributed to the higher density of crosslinkable IA moieties in IA-
PEG-600-Asp due to the shorter PEG units. This result indicates that improved gel content 
may be achieved by increasing the ratio of IA:Asp in the polymerization, and perhaps 
shortening the PEG length to 400 g/mol by retaining solubility of the resulting polymer. 
The mass swelling of the hydrogels, which measures the % change between their swollen 
mass and initial mass, was different between IA-PEG-600-Asp (149%) and IA-PEG-
1500-Asp (330%). Higher swelling of the IA-PEG-1500-Asp can be attributed to the 
increased hydrophilicity of the gel arising from incorporation of PEG 1500 relative to PEG 
600. The increased hydrophilicity likely allowed for more water to be absorbed and 
retained within the network. In addition, the lower gel content for IA-PEG-1500-Asp 
suggests that a lower crosslink density was likely obtained in the hydrogel network 
compared to that of IA-PEG-600-Asp, and a lower crosslink density would allow for more 
swelling. The equilibrium water content represents the proportion of water in the gel 
compared to dry mass of the polymer. Consistent with the higher swelling of IA-PEG-
1500-Asp hydrogels compared to IA-PEG-600-Asp hydrogels, the IA-PEG-1500-Asp 
had higher equilibrium water content.  
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Table 3.2. Characterization of IA-PEG-600-Asp and IA-PEG-1500-Asp hydrogels 
based on their mass swelling ratio, equilibrium water content, gel content and mechanical 
properties.  All data were analyzed by two-way ANOVA with a Tukey’s post-hoc 
comparison of the means (p < 0.05). * denotes statistically significant difference 
compared to the other group. 
Polymer Gel content 
(%) 
Mass swelling 
ratio (%) 
Equilibrium 
water content 
(%) 
Compressive 
Modulus (kPa) 
IA-PEG-600-
Asp 
48 ± 3* 149 ± 17* 95 ± 0.5* 742 ± 107* 
IA-PEG-1500-
Asp 
31 ± 5 330 ± 17 98 ± 0.5 54 ± 3 
The compressive moduli of IA-PEG-600-Asp and IA-PEG-1500-Asp gels were evaluated 
under unconfined compression on the CellSCale Microsquisher system. IA-PEG-600-Asp 
presented a higher compressive modulus of 742 ± 107 relative to 54 ± 3 produced by IA-
PEG-1500-Asp (Table 3.2). The difference in the moduli is likely due to the higher degree 
of swelling and reduced gel content of IA-PEG-1500-Asp. Additionally, the higher gel 
content and thus presumed higher crosslinking density in the IA-PEG-600-Asp networks 
likely increased the compressive modulus. The moduli of IA-PEG-600-Asp is similar to 
that of cartilage, while the modulus of IA-PEG-1500-Asp is similar to that found in muscle 
and skin tissue.  
SEM micro-graphs were obtained for the IA-PEG-600-Asp and IA-PEG-1500-Asp 
hydrogels. As shown in Figure 3.5, although the networks collapsed to same extent in the 
dry state, evidence of the porous structures was observed in both gels, which allows for 
transport of nutrients and waste in and out of the hydrogel. While it is difficult to make 
conclusions about the water-swollen gels from images of the dried gels due to possible 
drying artifacts, the pores look generally larger in the IA-PEG-1500-Asp hydrogels, which 
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would be consistent with their lower gel content, higher swelling, and higher equilibrium 
water content.  
 
Figure 3.4. SEM micro- graphs of a) IA-PEG-600-Asp and b) IA-PEG-1500-Asp  at 
300x magnification showing their porous structure and 3-dimensional topographical 
architecture.  
 
3.4 Conclusions  
We have demonstrated for the first time the successful synthesis of biomedical hydrogels 
containing IA and Asp. The polymers were synthesized through a transesterification 
reaction and varied in the length of their PEG component. The crosslinking of the different 
functionalized polymers to form hydrogels was investigated. Initiation with KPS/TEMED 
led to crosslinking of IA-PEG-600-Asp and IA-PEG-1500-Asp polymers in PBS. IA-
PEG-200-Asp did not crosslink under these conditions due to its poor solubility. IA-PEG-
1500-Asp had a reduced gel content compared to IA-PEG-600-Asp which resulted in 
increased swelling and equilibrium water content of the IA-PEG-1500-Asp hydrogel. The 
modulus of the IA-PEG-600-Asp hydrogel is similar to that of cartilage, while the modulus 
of IA-PEG-1500-Asp is similar to that found in muscle and skin tissue. Overall the 
polymer and hydrogel synthesis and characterization of these systems presents a promising 
platform for further tissue engineering applications. In the future, it will be important to 
increase the gel content of the hydrogels, which can possibly be achieved by increasing the 
density of IA moieties in the polymer backbone. We can also explore functionalizing the 
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remaining pendent groups of the hydrogel with cell-adhesive moieties such as RGD or 
other cell signaling molecules, either before or after gelation. 
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4 Summary and future work   
This thesis presented a new library of water-soluble polymers that are derived from both 
natural and synthetic components. These polymers contained a variety of crosslinkable 
moieties and were used to synthesize hydrogels for potential tissue engineering 
applications.  
Chapter 2 explored new polymers that were synthesized from Asp and PEG. PEG was 
introduced to impart water solubility and both PEG 600 and PEG 1500 were investigated. 
The Asp moieties provided amine pendent groups for modification. Using 
polycondensation reactions, BOC-protected polymers with Mn values of about 10 kg/mol 
were produced with Đ values ranging from 1.8 to 2.4. These polymers then underwent a 
successful BOC deprotection reactions, providing pendent amines and these amines were 
functionalized with ME, MA and IA. The conditions for functionalization were optimized 
to allow for > 95% functionalization of ME and MA while a maximum IA functionalization 
of 81% was achieved. UV light and thermally initiated free radical crosslinking attempts 
were conducted on the polymer systems. Of the 3 functional groups, only the ME 
functionalized polymers were able to form hydrogels. Formulations containing 10 and 20 
wt% polymer were prepared. Concentrations of 10 mM and 20 mM of both KPS and 
TEMED were used. Of the 4 conditions measured, the gels that were produced with 10 wt 
% polymer and 10 mM of initiator had high gel content of > 95 % and were selected for 
further characterization. The mechanical testing data showed that the Asp-PEG-600-ME 
gel had a compressive modulus of 6200 ± 2700 kPa and Asp-PEG-1500-ME had a 
compressive modulus of 9300 ± 3700 kPa which is slightly greater than that of cartilage.1A 
live dead study was conducted to asceses the cell viability of the hydrogel system. The 
study showed qualitatively that the hydrogels supported viable ACSs at both the 24 and 72 
h time points. 
While these polymer systems show a great deal of potential for application in the field of 
tissue engineering, there is still further research needed. Although these polymers are 
intended to crosslink, they have been observed to crosslink prematurely during storage. 
This can be overcome by storing the polymer with a radical inhibitor; however, a system 
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would need to be designed for the facile removal of the inhibitor before crosslinking. The 
polymers may also encounter some difficulty during scaleup due to the dialysis method 
used to purify the polymer. Different techniques such as extraction and precipitation can 
be studied to purify the polymers. Once the additional chemistry has been fully explored, 
a specific target tissue should be selected. Various formulations and further mechanical 
testing should be conducted to mimic the mechanical properties of the selected tissue. 
Relative to other hydrogels used for tissue engineering, these hydrogels possess a high 
compressive modulus. While this may be favorable, more mechanical testing is needed to 
assess the properties of the hydrogels such as their resilience. These tests include fatigue 
testing under cyclic compression and tensile testing. A rheological analysis could also be 
performed in order to better understand the physical properties of the gel. Future work for 
this chapter could involve additional crosslinking methods for the methacrylate group. 
For example, Michael addition chemistry could be used to incorporate dithiols as 
crosslinkers. Additionally, more biological testing using the ACSs should be conducted 
including: a quantitative analysis of the LIVE/DEAD® assay results, a MTT metabolic 
assay, in vitro cytokine release, and a cell proliferation and endothelial cell recruitment 
study. If favourable results are obtained, based on the mechanical properties of the 
hydrogels, they could potentially be used for the development of engineered cartilage. 
This possibility should be examined by investigated the potential for the ACSs to 
differentiate along the chondrocyte lineage in the hydrogels. Longer term, in vivo testing 
in animal models would be needed to examine the host response to the materials and their 
potential to support tissue regeneration in vivo. Ultimately, if testing in animal models 
goes well, clinical trials would need to be conducted with approval of the FDA or Health 
Canada.  
The initial goal of the thesis was to incorporate the IA into polymers that are used for 
biomedical applications. IA is attractive for use in biomedical polymers due to its anti-
inflammatory properties and regulation of tumor progression.2-3 While not all of the work 
is reported in this thesis, over 400 reactions were dedicated to incorporating IA into the 
backbone of polymers with limited success. Through the numerous failed reactions, a 
variety of methods and techniques were learned which led to the development of a 
titanium catalysed polycondensation process described in Chapter 3. This process 
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involved a transesterification reaction and allowed for IA to be introduced into the 
backbone of water-soluble polyesters. These polyesters were further enhanced by the 
incorporation of Asp into the backbone to introduce naturally occurring amino acids and 
also pendent amines for potential future functionalization of the hydrogel. Different PEG 
molar masses of 200, 600 and 1500 g/mol were investigated and the resulting polymers 
were found to have a Mn values between 6.3 and 10.1 kg/mole and a Đ values between 
2.5 and 2.9.  The polymers underwent a successful deprotection reaction to cleave the 
BOC groups that were protecting the pendent amines of Asp and salt exchange dialysis 
was conducted to remove the trifluoroacetate anion and replace it with chloride. The 
polymers were then investigated for their crosslinking properties. UV light-initiated 
curing was investigated but also did not crosslink the polymers in the required 4-minute 
timeframe. Finally, a thermally-initiated free radical crosslinking method was 
investigated, which led to the development of hydrogels. IA-PEG-200-Asp did not 
produce a gel, likely due to its poor water solubility. The crosslinked hydrogels, IA-PEG-
600-Asp and IA-PEG-1500-Asp were assessed based on their water content, EWC and 
gel content. It was found that IA-PEG-600-Asp and IA-PEG-1500-Asp underwent a large 
degree of swelling of 149% and 330%. The large degree of swelling was indicative of 
their low gel content of < 50%.  The mechanical properties of the hydrogels were 
assessed, and they were found to have a compressive modulus of 742 ± 107 kPa and 54 ± 
3 kPa for PEG-600-Asp and IA-PEG-1500-Asp respectively.  
 
The primary limitation of the hydrogel systems described in Chapter 3 are their low gel 
content of < 50%. This low gel content indicates that the polymers did not effectively 
crosslink. This low crosslinking was initially surprising given the highly reactive nature of 
the alkene present on IA, but can likely be attributed to the low content of IA relative to 
PEG and Asp. The gel content can be improved by increasing the ratio of IA:Asp or 
possibly using PEG 400 as the diol, both of which would increase the amount of IA within 
the system. Furthermore, different crosslinking techniques can be used such as Michael 
addition to the polymer with PEG dithiols. Although the protonated amino group may 
exhibit antimicrobial properties which could be interesting to investigate, the polymers can 
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be improved by using that group for further functionalization. The addition of a natural 
polymer such as gelatin would likely promote cellular adhesion and potentially 
differentiation. A degradation study of the polymer should also be conducted that would 
measure the amount of IA released from the system. These chemical modifications should 
be implemented, and a gel content of > 95% should be realized before moving on to further 
mechanical and biological testing.  
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Appendix 2 - Supporting information for Chapter 2: 
Functionalized Water-Soluble Polyesters for Potential 
Tissue Engineering Applications  
 
1H NMR spectra of the polymers  
 
 
Figure A2.1. 1H NMR spectrum of Asp-PEG-1500-BOC (CDCl3, 400 MHZ). 
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Figure A2.2. 1H NMR spectrum of Asp-PEG-600-BOC (CDCl3, 400 MHz). 
 
 
Figure A2.3. 1H NMR spectrum of Asp-PEG-1500 (CDCl3, 400 MHz). 
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Figure A2.4. 1H NMR spectrum of Asp-PEG-600 (CDCl3, 400 MHZ). 
 
Figure A2.5. 1H NMR spectrum of Asp-PEG-1500-ME (CDCl3, 400 MHz). 
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Figure A2.6. 1H NMR spectrum of Asp-PEG-600-ME (CDCl3, 400 MHz). 
 
Figure A2.7. 1H NMR spectrum of Asp-PEG-1500-MA (CDCl3, 400 MHz). 
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Figure A2.8. 1H NMR spectrum of Asp-PEG-600-MA (CDCl3, 400 MHz). 
 
Figure A2.9. 1H NMR spectrum of Asp-PEG-1500-IA in (CDCl3, 400 MHz). 
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Figure A2.10. 1H NMR spectrum of Asp-PEG-600-IA (CDCl3, 400 MHz). 
13C NMR spectra for the polymers  
 
 
Figure A2.11. 13C NMR spectrum of Asp-PEG-1500-BOC (CDCl3, 100 MHz). 
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Figure A2.12. 13C NMR spectrum of Asp-PEG-600-BOC (CDCl3, 100 MHz). 
 
 
Figure A2.13. 13C NMR spectrum of Asp-PEG-1500 (CDCl3, 100 MHz). 
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Figure A2.14. 13C NMR spectrum of Asp-PEG-600 (CDCl3, 100 MHz). 
 
Figure A2.15. 13C NMR spectrum of Asp-PEG-1500-ME (CDCl3, 100 MHz). 
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Figure A2.16. 13C NMR spectrum of Asp-PEG-600-ME (CDCl3, 100 MHz). 
 
Figure A2.17. 13C NMR spectrum of Asp-PEG-1500-MA (CDCl3, 100 MHz). 
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Figure A2.18. 13C NMR spectrum of Asp-PEG-600-MA (CDCl3, 100 MHz). 
 
Figure A2.19. 13C NMR spectrum of Asp-PEG-1500-IA (CDCl3, 100 MHz). 
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Figure A2. 20. 13C NMR spectrum of Asp-PEG-1500-IA (CDCl3, 100 MHz). 
FTIR spectra of the polymers 
 
Figure A2.21. FT-IR spectra of ASP-PEG-1500-BOC and ASP-PEG-1500 polymers.  
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Figure A2.22. FT-IR Spectra of a) ASP-PEG-1500-ME b) ASP-PEG-1500-MA c) ASP-
PEG-1500-IA 
 
SEC chromatograms for the polymers  
 
116 
 
Figure A2.23. SEC traces of functionalized polymers.  
Hydrogel characterization  
Table A2.2. Table indicating mass swelling ratio, equilibrium water content, gel content 
and compressive modulus of selected hydrogels.  
Gel formulation (polymer name, 
wt%, initiator concentration)  
Mass 
swelling 
ratio (%) 
Equilibrium 
water 
content (%) 
Gel content.   
(%) 
Compressive 
Modulus  
(kPa) 
Asp-PEG-600-ME (20wt%, 
20mM) 14 ± 6 80 ± 2 95 ± 6 
- 
Asp-PEG-1500-ME (20wt%, 
20mM) 19 ± 2 86 ± 0.5 81 ± 2 
- 
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Asp-PEG-600-ME (20wt%, 
10mM) 48 ± 4 97 ± 0.8 16 ± 6 
- 
Asp-PEG-1500-ME (20wt%, 
10mM) 12 ± 1 87 ± 0.5 70 ± 2 
- 
Asp-PEG-600-ME (10wt%, 
20mM) 10 ± 1 89 ± 0.3 94 ± 4 
- 
Asp-PEG-1500-ME (10wt%, 
20mM) 16 ± 0.3 93 ± 0.2 70 ± 2 
- 
Asp-PEG-600-ME (10wt%, 
10mM) 13.7 ± 1.97 91.2 ± 1.35 99 ± 16 
6200 ± 2700  
Asp-PEG-1500-ME (10wt%, 
10mM) 
12.3 ± 
0.731 91.3 ± 1.03 97 ± 11 
9300 ± 3700 
 
 
Appendix 3 - Supporting information for Chapter 3: 
Development of hydrogels composed of functionalized 
itaconic acid-containing polyesters 
 
1H NMR spectra of the polymers  
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Figure A3.1. 1H NMR spectrum of IA-PEG-200-Asp-BOC (CDCl3, 400 MHZ). 
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Figure A3.2. 1H NMR spectrum of IA-PEG-600-Asp-BOC (CDCl3, 400 MHZ). 
 
Figure A3.3. 1H NMR spectrum of IA-PEG-1500-Asp-BOC (CDCl3, 400 MHZ). 
 
 
120 
 
Figure A3.4. 1H NMR spectrum of IA-PEG-200-Asp (CDCl3, 400 MHZ). 
 
Figure A3.5. 1H NMR spectrum of IA-PEG-600-Asp (CDCl3, 400 MHZ). 
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Figure A3.6. 1H NMR spectrum of IA-PEG-1500-Asp (CDCl3, 400 MHZ). 
13C NMR spectra for the polymers 
 
Figure A3.7. 13C NMR spectrum of IA-PEG-200-Asp-BOC (CDCl3, 100 MHz). 
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Figure A3.8. 13C NMR spectrum of IA-PEG-600-Asp-BOC (CDCl3, 100 MHz). 
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Figure A3.9. 13C NMR spectrum of IA-PEG-1500-Asp-BOC (CDCl3, 100 MHz). 
 
Figure A3.10. 13C NMR spectrum of IA-PEG-200-Asp (CDCl3, 100 MHz). 
 
Figure A3.11. 13C NMR spectrum of IA-PEG-600-Asp (CDCl3, 100 MHz). 
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Figure A3.12. 13C NMR spectrum of IA-PEG-1500-Asp (CDCl3, 100 MHz). 
FT-IR spectra of the polymers 
 
Figure A3.13. FT-IR spectra of (a) IA-PEG-200-Asp (b), IA-PEG-600-Asp (c), IA-PEG-
1500-Asp 
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SEC chromatograms for the polymers  
 
Figure A3.14. SEC traces of IA-PEG-200-Asp-BOC, IA-PEG-600-Asp-BOC and IA-
PEG-1500-Asp-BOC. 
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